Helen of Troy Limited (HELE) 10-Q 9 Jan 18 2018 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Nov. 30, 2017	Jan. 04, 2018
Document and Entity Information
Entity Registrant Name	HELEN OF TROY LTD
Entity Central Index Key	916,789
Document Type	10-Q
Document Period End Date	Nov. 30, 2017
Amendment Flag	false
Current Fiscal Year End Date	--02-28
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		26,968,072
Document Fiscal Year Focus	2,018
Document Fiscal Period Focus	Q3

Consolidated Condensed Balance

Consolidated Condensed Balance Sheets - USD ($) $ in Thousands	Nov. 30, 2017	Feb. 28, 2017
Assets, current:
Cash and cash equivalents	$ 21,157	$ 23,087
Receivables - principally trade, less allowances of $9,624 and $5,655	302,390	229,928
Inventory	285,594	289,122
Prepaid expenses and other current assets	13,505	11,699
Income taxes receivable		2,242
Total assets, current	622,646	556,078
Property and equipment, net of accumulated depreciation of $118,485 and $106,561	132,989	134,935
Goodwill	602,320	698,929
Other intang1ible assets, net of accumulated amortization of $184,937 and $165,388	369,201	419,489
Deferred tax assets, net	44,590	1,955
Other assets, net of accumulated amortization of $1,999 and $1,930	3,149	1,710
Total assets	1,774,895	1,813,096
Liabilities, current:
Accounts payable, principally trade	109,196	111,763
Accrued expenses and other current liabilities	174,532	153,200
Income taxes payable	54,538
Long-term debt, current maturities	20,860	24,404
Total liabilities, current	359,126	289,367
Long-term debt, excluding current maturities	405,331	461,211
Deferred tax liabilities, net	8,153	20,091
Other liabilities, noncurrent	17,875	21,661
Total liabilities	790,485	792,330
Commitments and contingencies
Stockholders' equity:
Cumulative preferred stock, non-voting, $1.00 par. Authorized 2,000,000 shares; none issued
Common stock, $0.10 par. Authorized 50,000,000 shares; 26,960,863 and 27,028,665 shares issued and outstanding	2,696	2,703
Additional paid in capital	228,143	218,760
Accumulated other comprehensive income (loss)	(1,338)	1,173
Retained earnings	754,909	798,130
Total stockholders' equity	984,410	1,020,766
Total liabilities and stockholders' equity	$ 1,774,895	$ 1,813,096

Consolidated Condensed Balance3

Consolidated Condensed Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Nov. 30, 2017	Feb. 28, 2017
Consolidated Condensed Balance Sheets
Receivables - principally trade, allowances (in dollars)	$ 9,624	$ 5,656
Property and equipment, accumulated depreciation (in dollars)	118,485	106,561
Other intangible assets, accumulated amortization (in dollars)	184,937	165,388
Other assets, accumulated amortization (in dollars)	$ 1,999	$ 1,930
Cumulative preferred stock, non-voting, par (in dollars per share)	$ 1	$ 1
Cumulative preferred stock, non-voting, Authorized shares	2,000,000	2,000,000
Cumulative preferred stock, non-voting, issued shares	0	0
Common stock, par (in dollars per share)	$ 0.10	$ 0.10
Common stock, Authorized shares	50,000,000	50,000,000
Common stock, shares issued	26,960,863	27,028,665
Common stock, shares outstanding	26,960,863	27,028,665

Consolidated Condensed Statemen

Consolidated Condensed Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 30, 2017	Nov. 30, 2016	Nov. 30, 2017	Nov. 30, 2016
Consolidated Condensed Statements of Operations
Sales revenue, net	$ 453,045	$ 444,414	$ 1,191,112	$ 1,160,522
Cost of goods sold	251,271	250,199	664,956	650,912
Gross profit	201,774	194,215	526,156	509,610
Selling, general and administrative expense ("SG&A")	133,894	130,896	387,332	378,506
Asset impairment charges	82,227		136,297	7,400
Restructuring charges	1,283		1,283
Operating income (loss)	(15,630)	63,319	1,244	123,704
Nonoperating income, net	34	106	281	343
Interest expense	(3,619)	(3,625)	(11,327)	(11,142)
Income (loss) before income taxes	(19,215)	59,800	(9,802)	112,905
Income tax expense (benefit):
Current	46,625	4,928	60,188	16,625
Deferred	(35,404)	(2,740)	(54,355)	(8,713)
Net income (loss)	$ (30,436)	$ 57,612	$ (15,635)	$ 104,993
Earnings (loss) per share:
Basic (in dollars per share)	$ (1.12)	$ 2.10	$ (0.58)	$ 3.79
Diluted (in dollars per share)	$ (1.12)	$ 2.07	$ (0.58)	$ 3.74
Weighted average shares of common stock used in computing net earnings per share:
Basic (in shares)	27,113	27,484	27,140	27,700
Diluted (in shares)	27,113	27,802	27,140	28,058

Consolidated Condensed Stateme5

Consolidated Condensed Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 30, 2017	Nov. 30, 2016	Nov. 30, 2017	Nov. 30, 2016
Income (loss)	$ (19,215)	$ 59,800	$ (9,802)	$ 112,905
Cash flow hedge activity, before tax
Subtotal	1,600	1,527	(3,483)	1,814
Total OCI, before tax	2,353	1,527	(2,730)	1,814
Comprehensive income, before tax	(16,862)	61,327	(12,532)	114,719
Cash flow hedge activity, tax
Income tax (expense) benefit	(11,221)	(2,188)	(5,833)	(7,912)
Subtotal	(454)	(297)	509	(392)
Total OCI, tax	(744)	(297)	219	(392)
Comprehensive income, Tax	(11,965)	(2,485)	(5,614)	(8,304)
Net income (loss)	(30,436)	57,612	(15,635)	104,993
Cash flow hedge activity, net of tax
Subtotal	1,146	1,230	(2,974)	1,422
Total OCI	1,609	1,230	(2,511)	1,422
Comprehensive income, net of tax	(28,827)	58,842	(18,146)	106,415
Interest rate swaps
Cash flow hedge activity, before tax
Changes in fair market value	753		753
Subtotal	753		753
Cash flow hedge activity, tax
Changes in fair market value	(290)		(290)
Subtotal	(290)		(290)
Total OCI, tax			(290)
Cash flow hedge activity, net of tax
Changes in fair market value	463		463
Subtotal	463		463
Total OCI			463
Foreign currency contracts
Cash flow hedge activity, before tax
Changes in fair market value	2,928	2,049	(1,275)	2,319
Settlements reclassified to income	(1,328)	(522)	(2,208)	(505)
Cash flow hedge activity, tax
Changes in fair market value	(725)	(370)	75	(412)
Settlements reclassified to income	271	73	434	20
Total OCI, tax			509
Cash flow hedge activity, net of tax
Changes in fair market value	2,203	1,679	(1,200)	1,907
Settlements reclassified to income	$ (1,057)	$ (449)	(1,774)	$ (485)
Total OCI			$ (2,974)

Consolidated Condensed Stateme6

Consolidated Condensed Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Nov. 30, 2017	Nov. 30, 2016
Cash provided by operating activities:
Net income (loss)	$ (15,635)	$ 104,993
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	32,362	33,323
Amortization of financing costs	976	876
Provision for doubtful receivables	2,076	1,489
Non-cash share-based compensation	11,130	11,661
Non-cash intangible asset impairment charges	136,297	7,400
Gain (loss) on the sale or disposal of property and equipment	(10)	167
Deferred income taxes and tax credits	(54,355)	(8,769)
Changes in operating capital, net of effects of acquisition of business:
Receivables	(74,538)	(66,005)
Inventories	3,528	7,001
Prepaid expenses and other current assets	(2,850)	(2,134)
Other assets and liabilities, net	(1,532)	(3,772)
Accounts payable	(2,532)	29,004
Accrued expenses and other current liabilities	19,075	22,410
Accrued income taxes	53,637	1,496
Net cash provided by operating activities	107,629	139,140
Cash used in investing activities:
Capital and intangible asset expenditures	(19,854)	(14,989)
Proceeds from the sale of property and equipment	13	32
Payments to acquire businesses, net of cash acquired		(209,258)
Net cash used in investing activities	(19,841)	(224,215)
Cash used in financing activities:
Proceeds from line of credit	389,500	328,600
Repayment of line of credit	(444,200)	(380,600)
Repayment of long-term debt	(5,700)	(3,800)
Payment of financing costs		(89)
Proceeds from share issuances under share-based compensation plans	6,670	7,451
Payment of tax obligations resulting from cashless share award settlement	(6,830)	(507)
Payments for repurchases of common stock	(29,158)	(75,000)
Net cash used in financing activities	(89,718)	(123,945)
Net decrease in cash and cash equivalents	(1,930)	(209,020)
Cash and cash equivalents, beginning balance	23,087	225,800
Cash and cash equivalents, ending balance	$ 21,157	$ 16,780

Basis of Presentation and Relat

Basis of Presentation and Related Information	9 Months Ended
	Nov. 30, 2017
Basis of Presentation and and Related Information
Basis of Presentation and Related Information	Note 1 - Basis of Presentation and Related Information In this quarterly report on Form 10-Q and the accompanying consolidated condensed financial statements and notes thereto, unless otherwise indicated or the context suggests otherwise, references to “the Company”, “our Company”, “Helen of Troy”, “we”, “us”, or “our” refer to Helen of Troy Limited and its subsidiaries. References to “the FASB” refer to the Financial Accounting Standards Board. References to “GAAP” refer to U.S. generally accepted accounting principles. References to “ASU” refer to the codification of GAAP in the Accounting Standards Updates issued by the FASB. References to “ASC” refer to the codification of GAAP in the Accounting Standards Codification issued by the FASB. We incorporated as Helen of Troy Corporation in Texas in 1968 and were reorganized as Helen of Troy Limited in Bermuda in 1994. We are a global designer, developer, importer, marketer, and distributor of an expanding portfolio of brand-name consumer products. As of November 30, 2017, we had four segments: Housewares, Health & Home, Nutritional Supplements, and Beauty. Our Housewares segment provides a broad range of innovative consumer products for the home. Product offerings include food preparation tools and storage containers; cleaning, bath and garden tools and accessories; infant and toddler care products; and insulated beverage and food containers. The Health & Home segment focuses on healthcare devices such as thermometers, humidifiers, blood pressure monitors, and heating pads; water filtration systems; and small home appliances such as portable heaters, fans, air purifiers, and insect control devices. The Nutritional Supplements segment is a leading provider of premium branded vitamins, minerals and supplements, topical skin products and other health products sold directly to consumers, which was divested on December 20, 2017 (see Note 17 to these consolidated condensed financial statements). Our Beauty segment products include electric hair care, beauty care and wellness appliances; grooming tools and accessories; and liquid-, solid- and powder-based personal care and grooming products. The accompanying consolidated condensed financial statements contain all adjustments (consisting of only normal recurring adjustments) necessary to present fairly our consolidated financial position as of November 30, 2017 and February 28, 2017, and the results of our consolidated operations for the interim periods presented. We follow the same accounting policies when preparing quarterly financial data as we use for preparing annual data. These statements should be read in conjunction with the consolidated financial statements and the notes included in our latest annual report on Form 10-K for the fiscal year ended February 28, 2017, and our other reports on file with the Securities and Exchange Commission (the “SEC”). Our business is seasonal due to different calendar events, holidays and seasonal weather patterns. Historically, our highest sales volume and operating income occur in our third fiscal quarter ending November 30 th . We purchase our products from unaffiliated manufacturers, most of which are located in China, Mexico and the United States. The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in our consolidated condensed financial statements and accompanying notes. Actual results may differ materially from those estimates. Our consolidated condensed financial statements are prepared in United States (“U.S.”) Dollars. All intercompany accounts and transactions are eliminated in consolidation. We have reclassified, combined or separately disclosed certain amounts in the prior years’ consolidated condensed financial statements and accompanying footnotes to conform to the current year’s presentation.

New Accounting Pronouncements

New Accounting Pronouncements	9 Months Ended
	Nov. 30, 2017
New Accounting Pronouncements.
New Accounting Pronouncements	Note 2 – New Accounting Pronouncements Not Yet Adopted In August 2017, the FASB issued ASU 2017-12, Derivatives and Hedging –Targeted Improvements to Accounting for Hedging Activities (Topic 815) , which amends and simplifies hedge accounting with the intent of better aligning financial reporting for hedging relationships with an entity's risk management activities. The ASU is effective February 1, 2019. We are currently evaluating the effect this new accounting guidance may have on our consolidated financial position, results of operations and cash flows. In May 2017, the FASB issued ASU 2017-09, Compensation – Stock Compensation (Topic 718): Scope of Modification Accounting. This update amends the scope of modification accounting surrounding share-based payment arrangements as issued in ASU 2016-09 by providing guidance on the various types of changes which would trigger modification accounting for share-based payment awards. ASU 2017-09 is effective for annual periods beginning after December 15, 2017, and interim periods within those annual periods. We do not expect the adoption of ASU 2017-09 to have a material effect on our consolidated financial position, results of operations and cash flows. In October 2016, the FASB issued ASU 2016-16, Accounting for Income Taxes: Intra–Entity Asset Transfers of Assets Other Than Inventory. ASU 2016-16 amends accounting guidance for intra-entity transfers of assets other than inventory to require the recognition of taxes when the transfer occurs. The amendment will be effective for us in fiscal 2019. A modified retrospective approach will be required for transition to the new guidance, with a cumulative-effect adjustment consisting of the net impact from (1) the write-off of any unamortized expense previously deferred and (2) recognition of any previously unrecognized deferred tax assets, net of any valuation allowance. The new guidance does not include any specific new disclosure requirements. The new guidance may impact our effective tax rate, after adoption. We are currently evaluating the impact this guidance may have on our consolidated financial position, results of operations and cash flows. In February 2016, the FASB issued ASU 2016-02, Leases. ASU 2016-02 will require lessees to recognize on their balance sheets “right-of-use assets” and corresponding lease liabilities, measured on a discounted basis over the lease term. Virtually all leases will be subject to this treatment except leases that meet the definition of a “short-term lease.” For expense recognition, the dual model requiring leases to be classified as either operating or finance leases has been retained from the prior standard. Operating leases will result in straight-line expense while finance leases will result in a front-loaded expense pattern. Classification will use criteria very similar to those applied in current lease accounting, but without explicit bright lines. The new lease guidance will essentially eliminate off-balance sheet financing. The guidance is effective for us in fiscal 2020. The new standard must be adopted using a modified retrospective transition and requires the new guidance to be applied at the beginning of the earliest comparative period presented. We are currently evaluating the effect this new accounting guidance may have on our consolidated financial position, results of operations and cash flows. In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers , issued as a new Topic, ASC Topic 606. The new revenue recognition standard provides a five-step analysis of transactions to determine when and how revenue is recognized. The core principle of the guidance is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. We plan to adopt the new standard on March 1, 2018. If changes in policy or practice are required, we can adopt either retrospectively or as a cumulative effect adjustment as of the date of adoption. We continue to make progress in our assessment and implementation of the new standard. Our implementation approach has included a survey of revenue recognition policies and practices across each of our global reporting units, and a detailed study of the various types of commercial arrangements that we have with our customers to assess conformance of our current accounting practices with the new standard. While our completion of this assessment is ongoing, based on progress to date, we expect the new standard to primarily impact qualitative disclosure rather than materially effecting our accounting policies or practices. This is because our revenue is primarily generated from the sale of non-customized finished product to customers. Such sales contain a single delivery element and revenue is recognized at a single point in time when ownership, risks and rewards transfer. The accounting for these transactions is largely not impacted by the new standard. Unless otherwise discussed above, we believe the impact of recently issued standards that are not yet effective will not have a material impact on our consolidated financial position, results of operations and cash flows upon adoption. Adopted In January 2017, the FASB, issued ASU 2017-04, Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. This guidance provides for a single-step quantitative test to identify and measure impairment, requiring an entity to recognize an impairment charge for the amount by which the goodwill carrying amount exceeds the reporting unit’s fair value. We adopted the new guidance in the first quarter of fiscal 2018, applying it on a prospective basis. The application of this guidance has not had a material impact on our financial position, results of operations or cash flows.

Supplemental Balance Sheet Info

Supplemental Balance Sheet Information	9 Months Ended
	Nov. 30, 2017
Supplemental Balance Sheet Information
Supplemental Balance Sheet Information	Note 3 – Supplemental Balance Sheet Information PROPERTY AND EQUIPMENT Estimated Useful Lives November 30, February 28, (in thousands) (Years) 2017 2017 Land - $ 12,800 $ 12,800 Building and improvements - 40 109,108 109,026 Computer, furniture and other equipment - 15 89,838 81,122 Tools, molds and other production equipment - 10 33,792 31,157 Construction in progress - 5,936 7,391 Property and equipment, gross 251,474 241,496 Less accumulated depreciation (118,485) (106,561) Property and equipment, net $ 132,989 $ 134,935 ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES November 30, February 28, (in thousands) 2017 2017 Accrued compensation, benefits and payroll taxes $ 31,311 $ 34,917 Accrued sales returns, discounts and allowances 32,050 27,377 Accrued warranty returns 23,653 21,766 Accrued advertising 30,134 23,747 Accrued legal fees and settlements 17,282 16,908 Accrued royalties 10,599 9,553 Accrued property, sales and other taxes 9,509 6,564 Accrued freight and duty 5,480 3,454 Accrued product liability 2,224 2,141 Derivative liabilities, current 2,305 47 Liability for uncertain tax positions 1,024 - Other 8,961 6,726 Total accrued expenses and other current liabilities $ 174,532 $ 153,200 OTHER LIABILITIES, NONCURRENT November 30, February 28, (in thousands) 2017 2017 Deferred compensation liability $ 5,988 $ 6,560 Liability for uncertain tax positions 3,467 6,611 Other liabilities 8,420 8,490 Total other liabilities, noncurrent $ 17,875 $ 21,661

Acquisitions

Acquisitions	9 Months Ended
	Nov. 30, 2017
Acquisitions
Acquisitions	Note 4 – Acquisitions Hydro Flask Acquisition - On March 18, 2016, we completed the acquisition of all membership units of Steel Technology, LLC, doing business as Hydro Flask. Hydro Flask is a leading designer, distributor and marketer of high performance insulated stainless steel food and beverage containers for active lifestyles. The aggregate purchase price for the transaction was approximately $209.3 million, net of cash acquired. Significant assets acquired include receivables, inventory, prepaid expenses, property and equipment, trade names, technology assets, customer relationships, and goodwill. Acquisition-related expenses, incurred during fiscal 2016, were approximately $0.7 million (before and after tax). We accounted for the acquisition as the purchase of a business and recorded the excess purchase price as goodwill, which is not expected to be deductible for income tax purposes. We completed our analysis of the economic lives of all the assets acquired and determined the appropriate fair values of the acquired assets. We assigned $59.0 million to trade names with indefinite economic lives. We assigned $10.3 million to technology assets and $14.2 million to customer relationships and are amortizing these assets over expected lives of 10 and 24 years, respectively. For technology assets, we considered the average life cycle of the underlying products, which range from 7 - 15 years, and the overall average life of the associated patent portfolio. For the customer relationships, we used historical attrition rates to assign an expected life. The following schedule presents the net assets of Hydro Flask recorded at the acquisition date, excluding cash acquired: HYDRO FLASK - NET ASSETS RECORDED UPON ACQUISITION AT MARCH 18, 2016 (in thousands) Assets: Receivables $ 7,955 Inventory 6,243 Prepaid expenses and other current assets 336 Property and equipment 1,108 Goodwill 116,053 Trade names - indefinite 59,000 Technology assets - definite 10,300 Customer relationships - definite 14,200 Subtotal - assets 215,195 Liabilities: Accounts payable 2,275 Accrued expenses 3,662 Subtotal - liabilities 5,937 Net assets recorded $ 209,258 The fair values of the above assets acquired and liabilities assumed were estimated by applying income and market approaches. Key assumptions include various discount rates based upon a 12.3% weighted average cost of capital; royalty rates used in the determination of trade names and technology asset values of 6% and 2%, respectively; and a customer attrition rate used in the determination of customer relationship values of approximately 4% per year.

Goodwill and Intangible Assets

Goodwill and Intangible Assets	9 Months Ended
	Nov. 30, 2017
Goodwill and Intangible Assets
Goodwill and Intangible Assets	Note 5 – Goodwill and Intangible Assets Impairment Testing in Fiscal 2018 Nutritional Supplements During the third quarter of fiscal 2018, we continued to evaluate strategic alternatives for our Nutritional Supplements segment, including a transaction to divest the business. Over the short-term, certain of these alternatives may have a disproportionate impact on our income relative to the cost savings or generate other charges or losses. During the third quarter of fiscal 2018, we received new information regarding the potential fair value of our Nutritional Supplements segment that we concluded should be considered when determining if impairments of our long-lived assets, including goodwill, had occurred. Consequently, we performed interim impairment testing. As a result of our testing, we recorded pre-tax non-cash asset impairment charges totaling $82.2 million, consisting of $70.6 million to the segment’s goodwill and $11.6 million to the segment’s indefinite-lived brand assets. During the second quarter of fiscal 2018, we performed additional impairment testing for our Nutritional Supplements segment due to a revised financial projection. As a result of our testing, we recorded pre-tax non-cash asset impairment charges totaling $18.1 million to the segment’s indefinite-lived brand assets. During the first quarter of fiscal 2018, we received information regarding the potential fair value of our Nutritional Supplements segment that we concluded should be considered when determining if impairments of our long-lived assets, including goodwill, had occurred. Consequently, we performed interim impairment testing. As a result of our testing, we recorded pre-tax non-cash asset impairment charges totaling $32.0 million, consisting of $6.0 million to the segment’s indefinite-lived brand assets and $26.0 million to the segment’s goodwill. Beauty In our Beauty segment, we performed interim impairment testing in the first quarter of fiscal 2018 for a certain brand due to a revised financial projection. As a result of our testing, we recorded a pre-tax non-cash asset impairment charge of $4.0 million. The fair values used in our impairment tests were determined using a weighted average of various valuation methods including estimated future discounted cash flows and other market data. The valuation techniques utilized assumptions we believed to be appropriate in the circumstances; however, future circumstances attributable to a strategic change in our business could result in changes to those assumptions and other charges or losses relating our segments may be recorded and could be material. For example, if we determine that a divestiture is a probable outcome of our strategic reviews, we may need to perform additional impairment tests that may include future offer values. We are unable to project the amount of any expense, charge or loss that may be incurred in future periods. Impairment Testing in Fiscal 2017 Our annual impairment testing for goodwill and indefinite-lived intangible assets had historically occurred in the first quarter of our fiscal year. In December 2016, we elected to change our annual impairment testing to the fourth quarter of our fiscal year. Accordingly, for fiscal 2017 we completed impairment tests during the first and fourth fiscal quarters. As a result of our testing of indefinite-lived trademarks in the fourth quarter, we recorded non-cash asset impairment charges of $5.0 million ($3.2 million after tax). As a result of our testing of indefinite-lived trademarks in the first quarter, we recorded non-cash asset impairment charges of $7.4 million ($5.1 million after tax). The charges in both quarters were related to certain brand assets and trademarks in our Beauty and Nutritional Supplements segments, which were written down to their estimated fair values, determined on the basis of our estimated future discounted cash flows using the relief from royalty valuation method. The fair values used for our impairment testing in fiscal 2017 were estimated using a weighted average approach, which heavily weighted a valuation derived from a discounted cash flow model based on the Company’s estimates of future cash flows and based on management’s intentions with respect to the business. The following table summarizes the carrying amounts and associated accumulated amortization for all intangible assets by operating segment as of the end of the periods shown: GOODWILL AND INTANGIBLE ASSETS November 30, 2017 February 28, 2017 Gross Cumulative Gross Cumulative Carrying Goodwill Accumulated Net Book Carrying Goodwill Accumulated Net Book (in thousands) Amount Impairments Amortization Value Amount Impairments Amortization Value Housewares: Goodwill $ 282,056 $ - $ - $ 282,056 $ 282,056 $ - $ - $ 282,056 Trademarks - indefinite 134,200 - - 134,200 134,200 - - 134,200 Other intangibles - finite 40,751 - (17,074) 23,677 40,393 - (15,476) 24,917 Total Housewares 457,007 - (17,074) 439,933 456,649 - (15,476) 441,173 Health & Home: Goodwill 284,913 - - 284,913 284,913 - - 284,913 Trademarks - indefinite 54,000 - - 54,000 54,000 - - 54,000 Licenses - finite 15,300 - (15,300) - 15,300 - (15,300) - Licenses - indefinite 7,400 - - 7,400 7,400 - - 7,400 Other intangibles - finite 117,473 - (74,400) 43,073 116,982 - (66,027) 50,955 Total Health & Home 479,086 - (89,700) 389,386 478,595 - (81,327) 397,268 Nutritional Supplements: Goodwill 96,609 (96,609) - - 96,609 - - 96,609 Brand assets - indefinite 20,432 - - 20,432 56,020 - - 56,020 Other intangibles - finite 52,180 - (22,095) 30,085 44,180 - (16,715) 27,465 Total Nutritional Supplements 169,221 (96,609) (22,095) 50,517 196,809 - (16,715) 180,094 Beauty: Goodwill 81,841 (46,490) - 35,351 81,841 (46,490) - 35,351 Trademarks - indefinite 41,854 - - 41,854 45,854 - - 45,854 Trademarks - finite 150 - (96) 54 150 - (92) 58 Licenses - indefinite 10,300 - - 10,300 10,300 - - 10,300 Licenses - finite 13,696 - (12,087) 1,609 13,696 - (11,849) 1,847 Other intangibles - finite 46,402 - (43,885) 2,517 46,402 - (39,929) 6,473 Total Beauty 194,243 (46,490) (56,068) 91,685 198,243 (46,490) (51,870) 99,883 Total goodwill and intangible assets $ 1,299,557 $ (143,099) $ (184,937) $ 971,521 $ 1,330,296 $ (46,490) $ (165,388) $ 1,118,418 The following table summarizes the amortization expense attributable to intangible assets recorded in SG&A in the consolidated condensed statements of operations for the periods shown below, as well as our estimated amortization expense for fiscal 2018 through 2023. AMORTIZATION OF INTANGIBLE ASSETS Aggregate Amortization Expense (in thousands) For the three months ended November 30, 2017 $ 6,430 November 30, 2016 7,199 Aggregate Amortization Expense (in thousands) For the nine months ended November 30, 2017 $ 19,578 November 30, 2016 21,625 Estimated Amortization Expense (in thousands) Fiscal 2018 $ 26,095 Fiscal 2019 20,604 Fiscal 2020 19,516 Fiscal 2021 16,926 Fiscal 2022 6,450 Fiscal 2023 4,280

Share-Based Compensation Plans

Share-Based Compensation Plans	9 Months Ended
	Nov. 30, 2017
Share-Based Compensation Plans
Share-Based Compensation Plans	Note 6 – Share-Based Compensation Plans We have equity awards outstanding under several share-based compensation plans. During the three- and nine-months ended November 30, 2017, we had the following share-based compensation activity: · We issued 1,351 and 4,279 shares, respectively, to non-employee Board members with a total grant date fair value of $0.1 and $0.4 million, respectively, and average share prices of $90.80 and $94.26, respectively. · We granted time-vested restricted stock units (“RSUs”) that may be settled for 5,437 and 78,352 shares, respectively, of common stock with average fair values at the grant dates of $93.75 and $89.22 per unit, respectively. · We granted performance-based restricted stock units (“PSUs”) for 3,795 and 70,329 shares, respectively, of common stock with average fair values at the grant dates of $92.20 and $91.54 per unit, respectively. · Employee RSUs for 1,115 and 35,250 shares vested and settled with a total fair value at settlement of $0.1 and $3.5 million and an average share price of $91.97 and $98.13, respectively. · Employees exercised stock options to purchase 7,148 and 110,552 shares of common stock, respectively. During the three months ended May 31, 2017, employee PSUs for 149,884 shares vested and settled with a total fair value at settlement of $14.3 million, and an average share price of $95.55. We recorded the following share-based compensation expense in SG&A for the periods shown below: SHARE-BASED COMPENSATION EXPENSE Three Months Ended Nine Months Ended November 30, November 30, (in thousands, except per share data) 2017 2016 2017 2016 Stock options $ 327 $ 629 $ 1,289 $ 2,036 Directors stock compensation 175 175 575 525 Performance based and other stock awards 4,202 2,151 9,141 8,998 Employee stock purchase plan - - 297 258 Share-based compensation expense 4,704 2,955 11,302 11,817 Less income tax benefits (781) (706) (1,862) (2,920) Share-based compensation expense, net of income tax benefits $ 3,923 $ 2,249 $ 9,440 $ 8,897 Earnings per share impact of share-based compensation expense: Basic $ 0.14 $ 0.08 $ 0.35 $ 0.32 Diluted $ 0.14 $ 0.08 $ 0.35 $ 0.32

Repurchases of Helen of Troy Co

Repurchases of Helen of Troy Common Stock	9 Months Ended
	Nov. 30, 2017
Repurchase of Helen of Troy Common Stock
Repurchase of Helen of Troy Common Stock	Note 7 – Repurchase of Helen of Troy Common Stock On May 10, 2017, our Board of Directors authorized the repurchase of up to $400 million of our outstanding common stock. The new authorization is effective for a period of three years and replaced our existing repurchase authorization, of which approximately $82 million remained. These repurchases may include open market purchases, privately negotiated transactions, block trades, accelerated stock repurchase transactions, or any combination of such methods. The number of shares purchased and the timing of the purchases will depend on a number of factors, including share price, trading volume and general market conditions, working capital requirements, general business conditions, financial conditions, any applicable contractual limitations, and other factors, including alternative investment opportunities. As of November 30, 2017, our repurchase authorization allowed for the purchase of $364.9 million of common stock. Our current equity-based compensation plans include provisions that allow for the “net exercise” of share settled awards by all plan participants. In a net exercise, any required payroll taxes, federal withholding taxes and exercise price of the shares due from the option holder can be paid for by having the option holder tender back to the Company a number of shares at fair value equal to the amounts due. Net exercises are treated as purchases and retirements of shares. The following table summarizes our share repurchase activity for the periods shown: Three Months Ended November 30, Nine Months Ended November 30, (in thousands, except per share data) 2017 2016 2017 2016 Common stock repurchased on the open market or through tender offer: Number of shares 311,100 922,731 311,100 922,731 Aggregate value of shares $ 29,158 $ 75,000 $ 29,158 $ 75,000 Average price per share $ 93.72 $ 81.28 $ 93.72 $ 81.28 Common stock received in connection with share-based compensation: Number of shares 299 961 72,864 6,235 Aggregate value of shares $ 27 $ 83 $ 7,000 $ 590 Average price per share $ 91.94 $ 85.97 $ 96.07 $ 94.60

Restructuring Plan

Restructuring Plan	9 Months Ended
	Nov. 30, 2017
Restructuring Plan
Restructuring Plan	Note 8 – Restructuring Plan On October 5, 2017, the Company announced that it had approved a restructuring plan (referred to as “Project Refuel”) intended to enhance the performance of the Beauty and Nutritional Supplements segments. Project Refuel includes a reduction-in-force and the elimination of certain contracts. Following the divestiture of the Nutritional Supplements segment, as discussed in Note 17 to these consolidated condensed financial statements, the Company is targeting total annualized profit improvements of approximately $8.0 million over the duration of the plan. The Company estimates the plan to be completed by the first quarter of fiscal 2020, and expects to incur total restructuring charges in the range of approximately $3.2 to $4.8 million over the same period. Restructuring provisions are determined based on estimates prepared at the time the restructuring actions are approved by management and are revised periodically. Restructuring charges also include amounts recognized as incurred. During the three- and nine-months ended November 30, 2017, the Company incurred $1.3 million of pre-tax restructuring costs, of which $1.2 million pertained to employee severance and termination benefits in its Beauty segment and $0.1 million pertained to contract termination costs in its Nutritional Supplements segment. There were no restructuring costs during the comparable three- and nine-months ended November 30, 2016. As of November 30, 2017, the Beauty segment had made cash restructuring payments of $0.5 million and had a remaining liability of $0.7 million, and the Nutritional Supplements segment had a remaining liability of $0.1 million.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Nov. 30, 2017
Commitments and Contingencies
Commitments and Contingencies	Note 9 – Commitments and Contingencies Thermometer Patent Litigation – In January 2016, a jury ruled against the Company in a case that involved claims by Exergen Corporation. The case involved the alleged patent infringement related to two forehead thermometer models sold by our subsidiary, Kaz USA, Inc., in the United States. As a result of the jury verdict, we recorded a charge in fiscal 2016, including legal fees and other related expenses, of $17.8 million (before and after tax). In June 2016, certain post-trial motions were concluded with Exergen Corporation being awarded an additional $1.5 million of pre-judgment compensation. We accrued this additional amount in May 2016. In July 2016, we appealed the judgment to the United States Court of Appeals for the Federal Circuit. The Company continues to vigorously pursue its appellate rights and defend against the underlying judgment. Other Matters – We are involved in various other legal claims and proceedings in the normal course of operations, including from time to time inquiries and audits from various taxing authorities. We believe the outcome of these matters will not have a material adverse effect on our consolidated financial position, results of operations or liquidity, although the estimation of certain loss contingencies inherently involves some amount of uncertainty. Product Warranties – Most of our products are under warranty against defects in material and workmanship for periods ranging from two to five years. We estimate our warranty accrual using our historical experience and believe that this is the most reliable method by which we can estimate our warranty liability. The following table summarizes the activity in our warranty accrual for the periods shown: ACCRUAL FOR WARRANTY RETURNS Three Months Ended November 30, Nine Months Ended November 30, (in thousands) 2017 2016 2017 2016 Beginning balance $ 22,094 $ 19,459 $ 21,766 $ 20,622 Additions to the accrual 14,473 14,858 40,655 43,052 Reductions of the accrual - payments and credits issued (12,914) (12,457) (38,768) (41,814) Ending balance $ 23,653 $ 21,860 $ 23,653 $ 21,860 Notes 3, 10, 11 and 12 to these consolidated condensed financial statements provide additional information regarding certain of our significant commitments and contingencies.

Long-Term Debt

Long-Term Debt	9 Months Ended
	Nov. 30, 2017
Long-Term Debt
Long-Term Debt	Note 10 – Long-Term Debt We have a credit agreement (the “Credit Agreement”) with Bank of America, N.A., as administrative agent, and other lenders that provided for an unsecured total revolving commitment of $1 billion as of November 30, 2017. The commitment under the Credit Agreement terminates on December 7, 2021. Borrowings accrue interest under one of two alternative methods as described in the Credit Agreement. With each borrowing against our credit line, we can elect the interest rate method based on our funding needs at the time. We also incur loan commitment fees and letter of credit fees under the Credit Agreement. Outstanding letters of credit reduce the borrowing availability under the Credit Agreement on a dollar-for-dollar basis. As of November 30, 2017, the outstanding revolving loan principal balance was $386.0 million and the face amount of outstanding letters of credit was $7.6 million. For the three- and nine-months ended November 30, 2017, borrowings under the Credit Agreement incurred interest charges at rates ranging from 2.5% to 4.5% and 2.3% to 4.8%, respectively. For the three- and nine-months ended November 30, 2016, borrowings under the Credit Agreement incurred interest charges at rates ranging from 2.0% to 4.3% and 1.9% to 4.3%, respectively. As of November 30, 2017, the amount available for borrowings under the Credit Agreement was $606.4 million. Covenants in our debt agreements limit the amount of total indebtedness we can incur. As of November 30, 2017, these covenants effectively limited our ability to incur more than $348.2 million of additional debt from all sources, including our Credit Agreement. The following table summarizes our long-term debt as of the end of the periods shown: LONG-TERM DEBT Original Date Interest November 30, February 28, (dollars in thousands) Borrowed Rates Matures 2017 2017 Mississippi Business Finance Corporation Loan (the "MBFC Loan") (1) 03/13 Floating 03/23 $ 24,215 $ 29,903 Senior Notes (2) 01/11 3.9 % 01/18 19,976 19,763 Credit Agreement (3) 01/15 Floating 12/21 382,000 435,949 Total long-term debt 426,191 485,615 Less current maturities of long-term debt (20,860) (24,404) Long-term debt, excluding current maturities $ 405,331 $ 461,211 _____________________ (1) The MBFC Loan is unsecured with an original balance of $37.6 million and interest set and payable quarterly at a Base Rate, plus a margin of up to 1.0%, or applicable LIBOR plus a margin of up to 2.0%, as determined by the interest rate elected and the Leverage Ratio. The loan is subject to holder's call on or after March 1, 2018. The loan can be prepaid without penalty. The remaining principal balance of the MBFC Loan is payable as follows: $1.9 million annually on March 1, 2018 through 2022; and $14.8 million on March 1, 2023. Any remaining outstanding principal and interest is due upon maturity on March 1, 2023. (2) $100 million unsecured Senior Notes at a fixed interest rate of 3.9% payable semi-annually. Annual principal payments of $20 million began in January 2014. Prepayment of the notes are subject to a "make whole" premium. (3) Floating interest rates are hedged with and interest rate swap to effectively fix interest rates on $100 million of the outstanding principal balance under the Credit Agreement. Notes 11 and 12 to these consolidated condensed financial statements provide additional information regarding the interest rate swap. The fair market value of the fixed rate debt at November 30, 2017, computed using a discounted cash flow analysis and comparable market rates was $20.0 million, approximately equal to the $20.0 million book value. Our other long-term debt has floating interest rates, and its book value approximates its fair value at November 30, 2017. All of our debt is unconditionally guaranteed, on a joint and several basis, by the Company and certain of its subsidiaries. Our debt agreements require the maintenance of certain financial covenants, including maximum leverage ratios, minimum interest coverage ratios and minimum consolidated net worth levels (as each of these terms is defined in the various agreements). Our debt agreements also contain other customary covenants. We were in compliance with the terms of these agreements as of November 30, 2017.

Fair Value

Fair Value	9 Months Ended
	Nov. 30, 2017
Fair Value
Fair Value	Note 11 – Fair Value We classify our various assets and liabilities recorded or reported at fair value under a hierarchy prescribed by GAAP that prioritizes inputs to fair value measurement techniques into three broad levels: Level 1: Observable inputs such as quoted prices for identical assets or liabilities in active markets; Level 2: Observable inputs other than quoted prices that are directly or indirectly observable for the asset or liability, including quoted prices for similar assets or liabilities in active markets; quoted prices for similar or identical assets or liabilities in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable; and Level 3: Unobservable inputs that reflect the reporting entity’s own assumptions. Assets and liabilities subject to classification are classified upon acquisition. When circumstances dictate the transfer of an asset or liability to a different level, our policy is to recognize the transfer at the beginning of the reporting period in which the event resulting in the transfer occurred. The following tables present the fair value of our financial assets and liabilities measured on a recurring basis as of the end of the periods shown: FAIR VALUES OF FINANCIAL ASSETS AND LIABILITIES Fair Values at November 30, 2017 (in thousands) (Level 2) (1) Assets: Money market accounts $ 496 Interest rate swap and foreign currency contracts 1,023 Total assets $ 1,519 Liabilities: Fixed rate debt (2) $ 20,035 Floating rate debt 406,215 Foreign currency contracts 2,815 Total liabilities $ 429,065 Fair Values at February 28, 2017 (in thousands) (Level 2) (1) Assets: Money market accounts $ 2,711 Foreign currency contracts 2,167 Total assets $ 4,878 Liabilities: Fixed rate debt (2) $ 20,105 Floating rate debt 465,852 Foreign currency contracts 47 Total liabilities $ 486,004 _____________________ (1) Our financial assets and liabilities are classified as Level 2 because their valuation is dependent on observable inputs and other quoted prices for similar assets or liabilities, or model-derived valuations whose significant value drivers are observable. (2) Debt values are reported at estimated fair value in these tables, but are recorded in the accompanying consolidated balance sheets at the undiscounted value of remaining principal payments due. The carrying amounts of cash and cash equivalents, receivables and accounts payable approximate fair value because of the short maturity of these items. Money market accounts are included in cash and cash equivalents in the accompanying consolidated condensed balance sheets and are classified as Level 2 items. We use derivatives for hedging purposes and our derivatives are primarily interest rate swaps, foreign currency contracts and cross-currency debt swaps. See Notes 3, 12 and 13 to these consolidated condensed financial statements for more information on our hedging activities. We classify our fixed and floating rate debt as Level 2 items because the estimation of the fair market value of these financial assets requires the use of a discount rate based upon current market rates of interest for obligations with comparable remaining terms. Such comparable rates are considered significant other observable market inputs. The fair market value of the fixed rate debt was computed using a discounted cash flow analysis and discount rates of 0.3% at November 30, 2017 and 1.8% at February 28, 2017. All other long-term debt has floating interest rates, and its book value approximates its fair value as of the reporting date. Our other non-financial assets include goodwill and other intangible assets, which we classify as Level 3 items. These assets are measured at fair value on a non-recurring basis as part of our impairment testing. Note 5 to these consolidated condensed financial statements contains additional information regarding impairment testing and related intangible asset impairments.

Financial Instruments and Risk

Financial Instruments and Risk Management	9 Months Ended
	Nov. 30, 2017
Financial Instruments and Risk Management
Financial Instruments and Risk Management	Note 1 Foreign Currency Risk - Our functional currency is the U.S. Dollar. By operating internationally, we are subject to foreign currency risk from transactions denominated in currencies other than the U.S. Dollar (“foreign currencies”). Such transactions include sales, certain inventory purchases and operating expenses. As a result of such transactions, portions of our cash, trade accounts receivable and trade accounts payable are denominated in foreign currencies. During both the three- and nine-months ended November 30, 2017 and 2016, approximately 12% of our net sales revenue was in foreign currencies. These sales were primarily denominated in British Pounds, Euros, Mexican Pesos and Canadian Dollars. We make most of our inventory purchases from the Far East and primarily use the U.S. Dollar for such purchases. In our consolidated condensed statements of operations, exchange gains and losses resulting from the remeasurement of foreign taxes receivable, taxes payable, deferred tax assets, and deferred tax liabilities, are recognized in their respective income tax lines, and all other foreign exchange gains and losses from remeasurement of the balance sheet are recognized in SG&A. For the three- and nine-months ended November 30, 2017, we recorded net foreign exchange gains (losses) from remeasurement, including the impact of foreign currency hedges and cross-currency debt swaps, of $(2.2) and $(1.5) million, respectively, in SG&A, and $(0.1) and $(0.7) million, respectively, in income tax expense. For the three- and nine-months ended November 30, 2016, we recorded net foreign exchange gains (losses) from remeasurement, including the impact of foreign currency hedges and cross-currency debt swaps, of $(0.1) and $(0.6) million, respectively, in SG&A, and $(0.2) million and $(0.1) million, respectively, in income tax expense. We hedge against certain foreign currency exchange rate risk by using a series of forward contracts designated as cash flow hedges and mark-to-market derivatives to manage the foreign currency exchange risk inherent in our forecasted transactions denominated in currencies other than the U.S. Dollar. We do not enter into any forward exchange contracts or similar instruments for trading or other speculative purposes. Interest Rate Risk - Interest on our outstanding debt as of November 30, 2017 is both floating and fixed. Fixed rates are in place on $20 million of Senior Notes at 3.9% and floating rates are in place on the balance of all other debt outstanding, which totaled $410.3 million as of November 30, 2017. If short-term interest rates increase, we will incur higher interest rates on any future outstanding balances of floating rate debt. Borrowings under the Credit Agreement accrue interest (at the Company’s election) based on either a base rate, plus a margin of up to 1.00%, or the applicable LIBOR plus a margin of up to 2.00%, in each case, as determined by the Company’s leverage ratio, calculated pursuant to the Company’s Credit Agreement. During September 2017, the Company effectively converted $100 million of the outstanding principal balance under the Credit Agreement to fixed rate debt using an interest rate swap. The swap converted the total aggregate notional principal from floating LIBOR interest rate payments to fixed interest rate payments at rates ranging from approximately 1.5% to 2.1% for annual periods through December 2021, as compared to the one-month LIBOR rate of approximately 1.4% as of November 30, 2017. Changes in the spread between the fixed rate payment side of the swap and the floating rate receipt side of the swap offset 100 percent of the change in any period of the underlying debt’s floating rate payments. Therefore, the swap is considered 100 percent effective. The following table summarizes the fair values of our derivative instruments as of the end of the periods shown: FAIR VALUES OF DERIVATIVE INSTRUMENTS November 30, 2017 Prepaid Accrued Expenses Expenses Final and Other and Other Other (in thousands) Settlement Notional Current Other Current Liabilities, Derivatives designated as hedging instruments Hedge Type Date Amount Assets Assets Liabilities Non-current Foreign currency contracts - sell Euro Cash flow 12/2018 € 32,250 $ - $ 2 $ 1,381 $ - Foreign currency contracts - sell Canadian Dollars Cash flow 12/2018 $ 27,750 252 16 - - Foreign currency contracts - sell Pounds Cash flow 01/2019 £ 20,400 - - 765 32 Foreign currency contracts - sell Mexican Pesos Cash flow 05/2018 $ 45,000 - - 159 - Interest rate swap Cash flow 12/2021 $ 100,000 134 619 - - Subtotal 386 637 2,305 32 Derivatives not designated under hedge accounting Foreign currency contracts - cross-currency debt swaps - Euro (1) 4/2020 $ 5,280 - - - 65 Foreign currency contracts - cross-currency debt swaps - Pound (1) 4/2020 $ 6,395 - - - 413 Subtotal - - - 478 Total fair value $ 386 $ 637 $ 2,305 $ 510 February 28, 2017 Prepaid Accrued Expenses Expenses Final and Other and Other Other Settlement Notional Current Other Current Liabilities, Derivatives designated as hedging instruments Hedge Type Date Amount Assets Assets Liabilities Non-current Foreign currency contracts - sell Euro Cash flow 2/2018 € 27,500 $ 727 $ - $ - $ - Foreign currency contracts - sell Canadian Dollars Cash flow 6/2018 $ 26,000 155 32 - - Foreign currency contracts - sell Pounds Cash flow 2/2018 £ 13,500 548 - - - Foreign currency contracts - sell Mexican Pesos Cash flow 2/2018 $ 59,600 - - 47 - Subtotal 1,430 32 47 - Derivatives not designated under hedge accounting Foreign currency contracts - cross-currency debt swap - Euro (1) 1/2018 $ 10,000 705 - - - Total fair value $ 2,135 $ 32 $ 47 $ - _____________________ (1) These are foreign currency contracts for which we have not elected hedge accounting. We refer to them as “cross-currency debt swaps”. They, in effect, adjust the currency denomination of a portion of our outstanding debt to the Euro and British Pound, as applicable, for the notional amounts reported, creating an economic hedge against currency movements. The following table summarizes the pre-tax effect of derivative instruments for the periods shown: PRE-TAX EFFECT OF DERIVATIVE INSTRUMENTS Three Months Ended November 30, Gain (Loss) Gain (Loss) Reclassified from Recognized in OCI Accumulated Other Comprehensive Gain (Loss) Recognized (effective portion) Income (Loss) into Income As Income (in thousands) 2017 2016 Location 2017 2016 Location 2017 2016 Currency contracts - cash flow hedges $ 2,928 $ 2,049 SG&A $ 1,328 $ 522 $ - $ - Interest rate swaps - cash flow hedges 753 - Interest expense - - Interest expense (48) - Cross-currency debt swaps - principal - - - - SG&A (419) 493 Cross-currency debt swaps - interest - - - - Interest Expense 74 - Total $ 3,681 $ 2,049 $ 1,328 $ 522 $ (393) $ 493 Nine Months Ended November 30, Gain (Loss) Gain (Loss) Reclassified from Recognized in OCI Accumulated Other Comprehensive Gain (Loss) Recognized (effective portion) Income (Loss) into Income As Income (in thousands) 2017 2016 Location 2017 2016 Location 2017 2016 Currency contracts - cash flow hedges $ (1,275) $ 2,319 SG&A $ 2,208 $ 505 $ - $ - Interest rate swaps - cash flow hedges 753 - Interest expense - - Interest expense (48) - Cross-currency debt swaps - principal - - - - SG&A (1,183) 528 Cross-currency debt swaps - interest - - - - Interest Expense 74 35 Total $ (522) $ 2,319 $ 2,208 $ 505 $ (1,157) $ 563 We expect pre-tax net losses of $2.1 million associated with foreign currency contracts currently reported in accumulated other comprehensive income, to be reclassified into income over the next twelve months. The amount ultimately realized, however, will differ as exchange rates vary and the underlying contracts settle. Counterparty Credit Risk - Financial instruments, including foreign currency contracts and cross currency debt swaps, expose us to counterparty credit risk for nonperformance. We manage our exposure to counterparty credit risk by only dealing with counterparties who are substantial international financial institutions with significant experience using such derivative instruments. Although our theoretical credit risk is the replacement cost at the then-estimated fair value of these instruments, we believe that the risk of incurring credit losses is remote.

Comprehensive Income (Loss)

Comprehensive Income (Loss)	9 Months Ended
	Nov. 30, 2017
Comprehensive Income (Loss)
Comprehensive Income (Loss)	Note 13 – Comprehensive Income (Loss) The changes in accumulated other comprehensive income (loss) by component and related tax effects for the fiscal 2018 year-to-date are as follows: CHANGES IN ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) BY COMPONENT Unrealized Holding Gains (Losses) on Cash Flow Hedges (in thousands) Interest Rate Swaps (1) Foreign Currency Contracts (2) Total Balance at February 28, 2017 $ - $ 1,173 $ 1,173 Other comprehensive income (loss) before reclassification 753 (1,275) (522) Amounts reclassified out of accumulated other comprehensive income (loss) - (2,208) (2,208) Tax effects (290) 509 219 Other comprehensive income (loss) 463 (2,974) (2,511) Balance at November 30, 2017 $ 463 $ (1,801) $ (1,338) _____________________ (1) Includes net deferred tax benefits of $0.3 million at November 30, 2017. (2) Balances at November 30, 2017 and February 28, 2017 include net deferred tax benefit (expense) of $0.3 and $(0.2) million, respectively .

Segment Information

Segment Information	9 Months Ended
	Nov. 30, 2017
Segment Information
Segment Information	Note 14 – Se The following tables present segment information for the periods shown: THREE MONTHS ENDED (in thousands) Nutritional November 30, 2017 Housewares Health & Home Supplements Beauty Total Sales revenue, net $ 128,017 $ 190,975 $ 29,336 $ 104,717 $ 453,045 Asset impairment charges - - 82,227 - 82,227 Restructuring charges - - 118 1,165 1,283 Operating income (loss) 29,982 27,897 (83,521) 10,012 (15,630) Capital and intangible asset expenditures 565 171 1,802 502 3,040 Depreciation and amortization 1,444 4,232 2,374 2,710 10,760 Nutritional November 30, 2016 Housewares Health & Home Supplements Beauty Total Sales revenue, net $ 124,723 $ 179,842 $ 32,163 $ 107,686 $ 444,414 Asset impairment charges - - - - - Restructuring charges - - - - - Operating income (loss) 29,223 20,155 (80) 14,021 63,319 Capital and intangible asset expenditures 1,100 1,492 1,558 624 4,774 Depreciation and amortization 1,429 5,221 2,108 2,467 11,225 NINE MONTHS ENDED (in thousands) Nutritional November 30, 2017 Housewares (1) Health & Home Supplements Beauty Total Sales revenue, net $ 341,165 $ 489,102 $ 92,212 $ 268,633 $ 1,191,112 Asset impairment charges - - 132,297 4,000 136,297 Restructuring charges - - 118 1,165 1,283 Operating income (loss) 71,601 $ 50,187 $ (138,413) $ 17,869 1,244 Capital and intangible asset expenditures 1,166 1,381 14,561 2,746 19,854 Depreciation and amortization 4,290 12,553 7,223 8,296 32,362 Nutritional November 30, 2016 Housewares (1) Health & Home Supplements Beauty Total Sales revenue, net $ 315,302 $ 470,650 $ 101,215 $ 273,355 $ 1,160,522 Asset impairment charges - - 5,000 2,400 7,400 Restructuring charges - - - - - Operating income (loss) 68,956 39,156 (6,581) 22,173 123,704 Capital and intangible asset expenditures 3,938 3,526 3,665 3,860 14,989 Depreciation and amortization 4,200 15,738 6,242 7,143 33,323 _____________________ (1) The nine months ended November 30, 2017 includes a full nine months of operating results for Hydro Flask compared to eight and one-half months for the nine months ended November 30, 2016. We compute segment operating income based on net sales revenue, less cost of goods sold, SG&A, restructuring charges, and any asset impairment charges associated with the segment. The SG&A used to compute each segment’s operating income (loss) is directly associated with the segment, plus shared service and corporate overhead expenses that are allocable to the segment. We do not allocate nonoperating income and expense, including interest or income taxes, to operating segments.

Income Taxes

Income Taxes	9 Months Ended
	Nov. 30, 2017
Income Taxes
Income Taxes	Note 15 – Income Taxes Due to the Company’s organization in Bermuda and the ownership structure of its foreign subsidiaries, many of which are not owned directly or indirectly by a U.S. parent company, an immaterial amount of our foreign income is subject to U.S. taxation on a permanent basis under current law. Additionally, our intellectual property is largely owned by our foreign subsidiaries, resulting in proportionally higher earnings in jurisdictions with lower statutory tax rates, which decreases our overall effective tax rate. For the three months ended November 30, 2017, income tax expense as a percentage of pre-tax loss was (58.4)%, compared to expense of 3.7% for the same period last year, primarily due to the recognition of tax benefits from impairment charges over the course of the year in relation to pre-tax income, as opposed to the periods in which the charges were incurred. For the nine months ended November 30, 2017, income tax expense as a percentage of pre-tax loss was (59.5)% compared to expense of 7.0% for the same period last year, primarily due to the recognition of tax benefits from impairment charges over the course of the year in relation to pre-tax income as opposed to the periods in which the charges were incurred. As a result, the expected tax benefit from impairment charges of $52.8 million will be recognized entirely in the fourth quarter of fiscal 2018 relative to pre-tax income. Income taxes for the nine months ended November 30, 2017 also included: · $2.6 million in excess tax benefits from share-based compensation settlements and exercises; and · $2.8 million of tax benefits related to the resolution of uncertain tax positions. Income taxes for the nine months ended November 30, 2016 included tax benefits of $1.4 million related the resolution of uncertain tax positions, $1.6 million in excess tax benefits from share-based compensation settlements and exercises, and $1.2 million in tax benefits due to the finalization of certain tax returns.

Earnings per Share

Earnings per Share	9 Months Ended
	Nov. 30, 2017
Earnings per Share
Earnings per Share	Note 16 – Earnings per Share We compute basic earnings per share using the weighted average number of shares of common stock outstanding during the period. We compute diluted earnings per share using the weighted average number of shares of common stock outstanding plus the effect of dilutive securities. Dilutive securities at any given point in time may consist of outstanding options to purchase common stock and issued and contingently issuable unvested restricted share units (“RSUs”) and performance-based restricted share units (“PSUs”). Due to the net loss for the three and nine months ended November 30, 2017, 154,255 and 164,017 incremental shares from share-based compensation arrangements were excluded from the computation of diluted weighted average shares outstanding, respectively, because their effect would be anti-dilutive. Options for common stock are excluded from the computation of diluted earnings per share if their effect is antidilutive. See Note 6 to these consolidated condensed financial statements for more information regarding share-based compensation awards. The following table presents our basic and diluted shares for the periods shown: WEIGHTED AVERAGE DILUTED SECURITIES Three Months Ended November 30, Nine Months Ended November 30, (in thousands) 2017 2016 2017 2016 Weighted average shares outstanding, basic 27,113 27,484 27,140 27,700 Incremental shares from share-based compensation arrangements - 318 - 358 Weighted average shares outstanding, diluted 27,113 27,802 27,140 28,058 Dilutive securities, stock options 222 325 236 401 Dilutive securities, unvested or unsettled stock awards 82 163 100 163 Antidilutive securities 354 149 344 142

Subsequent Events

Subsequent Events	9 Months Ended
	Nov. 30, 2017
Subsequent Events
Subsequent Events	Note 17 – Subsequent Events Divestiture of the Nutritional Supplements Segment On December 20, 2017, the Company completed the sale of Healthy Directions LLC and its subsidiaries to Direct Digital, LLC. The purchase price from the sale is comprised of $46 million in cash, paid at closing, and a supplemental payment with a target value of $25 million, payable on or before August 1, 2019. The final amount of the supplemental payment may be adjusted up or down based on the performance of Healthy Directions through February 28, 2018. The final purchase price is also subject to a customary working capital adjustment. The transaction is not reflected in our consolidated condensed financial statements as of and for the period ended November 30, 2017. Tax Reform The Tax Cuts and Jobs Act was signed into law in December 2017, which represents significant U.S. federal tax reform legislation that includes a permanent reduction to the U.S. federal corporate income tax rate. The permanent reduction to the federal corporate income tax rate will have the effect of a one-time impact to the value of our deferred tax assets and liabilities. Additionally, we expect that the tax reform legislation will subject certain of our cumulative foreign earnings and profits to U.S. income taxes through a deemed repatriation. We are reviewing the recently enacted tax reform’s effects on our deferred tax assets and the taxation of certain foreign earnings and profits, and we expect to recognize the impact in the fourth quarter of fiscal 2018.

New Accounting Pronouncements (

New Accounting Pronouncements (Policies)	9 Months Ended
	Nov. 30, 2017
New Accounting Pronouncements
New Accounting Pronouncements	Not Yet Adopted In August 2017, the FASB issued ASU 2017-12, Derivatives and Hedging –Targeted Improvements to Accounting for Hedging Activities (Topic 815) , which amends and simplifies hedge accounting with the intent of better aligning financial reporting for hedging relationships with an entity's risk management activities. The ASU is effective February 1, 2019. We are currently evaluating the effect this new accounting guidance may have on our consolidated financial position, results of operations and cash flows. In May 2017, the FASB issued ASU 2017-09, Compensation – Stock Compensation (Topic 718): Scope of Modification Accounting. This update amends the scope of modification accounting surrounding share-based payment arrangements as issued in ASU 2016-09 by providing guidance on the various types of changes which would trigger modification accounting for share-based payment awards. ASU 2017-09 is effective for annual periods beginning after December 15, 2017, and interim periods within those annual periods. We do not expect the adoption of ASU 2017-09 to have a material effect on our consolidated financial position, results of operations and cash flows. In October 2016, the FASB issued ASU 2016-16, Accounting for Income Taxes: Intra–Entity Asset Transfers of Assets Other Than Inventory. ASU 2016-16 amends accounting guidance for intra-entity transfers of assets other than inventory to require the recognition of taxes when the transfer occurs. The amendment will be effective for us in fiscal 2019. A modified retrospective approach will be required for transition to the new guidance, with a cumulative-effect adjustment consisting of the net impact from (1) the write-off of any unamortized expense previously deferred and (2) recognition of any previously unrecognized deferred tax assets, net of any valuation allowance. The new guidance does not include any specific new disclosure requirements. The new guidance may impact our effective tax rate, after adoption. We are currently evaluating the impact this guidance may have on our consolidated financial position, results of operations and cash flows. In February 2016, the FASB issued ASU 2016-02, Leases. ASU 2016-02 will require lessees to recognize on their balance sheets “right-of-use assets” and corresponding lease liabilities, measured on a discounted basis over the lease term. Virtually all leases will be subject to this treatment except leases that meet the definition of a “short-term lease.” For expense recognition, the dual model requiring leases to be classified as either operating or finance leases has been retained from the prior standard. Operating leases will result in straight-line expense while finance leases will result in a front-loaded expense pattern. Classification will use criteria very similar to those applied in current lease accounting, but without explicit bright lines. The new lease guidance will essentially eliminate off-balance sheet financing. The guidance is effective for us in fiscal 2020. The new standard must be adopted using a modified retrospective transition and requires the new guidance to be applied at the beginning of the earliest comparative period presented. We are currently evaluating the effect this new accounting guidance may have on our consolidated financial position, results of operations and cash flows. In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers , issued as a new Topic, ASC Topic 606. The new revenue recognition standard provides a five-step analysis of transactions to determine when and how revenue is recognized. The core principle of the guidance is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. We plan to adopt the new standard on March 1, 2018. If changes in policy or practice are required, we can adopt either retrospectively or as a cumulative effect adjustment as of the date of adoption. We continue to make progress in our assessment and implementation of the new standard. Our implementation approach has included a survey of revenue recognition policies and practices across each of our global reporting units, and a detailed study of the various types of commercial arrangements that we have with our customers to assess conformance of our current accounting practices with the new standard. While our completion of this assessment is ongoing, based on progress to date, we expect the new standard to primarily impact qualitative disclosure rather than materially effecting our accounting policies or practices. This is because our revenue is primarily generated from the sale of non-customized finished product to customers. Such sales contain a single delivery element and revenue is recognized at a single point in time when ownership, risks and rewards transfer. The accounting for these transactions is largely not impacted by the new standard. Unless otherwise discussed above, we believe the impact of recently issued standards that are not yet effective will not have a material impact on our consolidated financial position, results of operations and cash flows upon adoption. Adopted In January 2017, the FASB, issued ASU 2017-04, Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. This guidance provides for a single-step quantitative test to identify and measure impairment, requiring an entity to recognize an impairment charge for the amount by which the goodwill carrying amount exceeds the reporting unit’s fair value. We adopted the new guidance in the first quarter of fiscal 2018, applying it on a prospective basis. The application of this guidance has not had a material impact on our financial position, results of operations or cash flows.

Supplemental Balance Sheet In25

Supplemental Balance Sheet Information (Tables)	9 Months Ended
	Nov. 30, 2017
Supplemental Balance Sheet Information
Schedule of property and equipment	Estimated Useful Lives November 30, February 28, (in thousands) (Years) 2017 2017 Land - $ 12,800 $ 12,800 Building and improvements - 40 109,108 109,026 Computer, furniture and other equipment - 15 89,838 81,122 Tools, molds and other production equipment - 10 33,792 31,157 Construction in progress - 5,936 7,391 Property and equipment, gross 251,474 241,496 Less accumulated depreciation (118,485) (106,561) Property and equipment, net $ 132,989 $ 134,935
Schedule of accrued expenses and other current liabilities	November 30, February 28, (in thousands) 2017 2017 Accrued compensation, benefits and payroll taxes $ 31,311 $ 34,917 Accrued sales returns, discounts and allowances 32,050 27,377 Accrued warranty returns 23,653 21,766 Accrued advertising 30,134 23,747 Accrued legal fees and settlements 17,282 16,908 Accrued royalties 10,599 9,553 Accrued property, sales and other taxes 9,509 6,564 Accrued freight and duty 5,480 3,454 Accrued product liability 2,224 2,141 Derivative liabilities, current 2,305 47 Liability for uncertain tax positions 1,024 - Other 8,961 6,726 Total accrued expenses and other current liabilities $ 174,532 $ 153,200
Schedule of other liabilities, noncurrent	November 30, February 28, (in thousands) 2017 2017 Accrued compensation, benefits and payroll taxes $ 31,311 $ 34,917 Accrued sales returns, discounts and allowances 32,050 27,377 Accrued warranty returns 23,653 21,766 Accrued advertising 30,134 23,747 Accrued legal fees and settlements 17,282 16,908 Accrued royalties 10,599 9,553 Accrued property, sales and other taxes 9,509 6,564 Accrued freight and duty 5,480 3,454 Accrued product liability 2,224 2,141 Derivative liabilities, current 2,305 47 Liability for uncertain tax positions 1,024 - Other 8,961 6,726 Total accrued expenses and other current liabilities $ 174,532 $ 153,200 OTHER LIABILITIES, NONCURRENT November 30, February 28, (in thousands) 2017 2017 Deferred compensation liability $ 5,988 $ 6,560 Liability for uncertain tax positions 3,467 6,611 Other liabilities 8,420 8,490 Total other liabilities, noncurrent $ 17,875 $ 21,661

Acquisitions (Tables)

Acquisitions (Tables)	9 Months Ended
	Nov. 30, 2017
Hydro Flask
Acquisitions
Schedule of net assets recorded upon acquisition	HYDRO FLASK - NET ASSETS RECORDED UPON ACQUISITION AT MARCH 18, 2016 (in thousands) Assets: Receivables $ 7,955 Inventory 6,243 Prepaid expenses and other current assets 336 Property and equipment 1,108 Goodwill 116,053 Trade names - indefinite 59,000 Technology assets - definite 10,300 Customer relationships - definite 14,200 Subtotal - assets 215,195 Liabilities: Accounts payable 2,275 Accrued expenses 3,662 Subtotal - liabilities 5,937 Net assets recorded $ 209,258

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	9 Months Ended
	Nov. 30, 2017
Goodwill and Intangible Assets
Summary of carrying amounts and associated accumulated amortization for all intangible assets by operating segment	GOODWILL AND INTANGIBLE ASSETS November 30, 2017 February 28, 2017 Gross Cumulative Gross Cumulative Carrying Goodwill Accumulated Net Book Carrying Goodwill Accumulated Net Book (in thousands) Amount Impairments Amortization Value Amount Impairments Amortization Value Housewares: Goodwill $ 282,056 $ - $ - $ 282,056 $ 282,056 $ - $ - $ 282,056 Trademarks - indefinite 134,200 - - 134,200 134,200 - - 134,200 Other intangibles - finite 40,751 - (17,074) 23,677 40,393 - (15,476) 24,917 Total Housewares 457,007 - (17,074) 439,933 456,649 - (15,476) 441,173 Health & Home: Goodwill 284,913 - - 284,913 284,913 - - 284,913 Trademarks - indefinite 54,000 - - 54,000 54,000 - - 54,000 Licenses - finite 15,300 - (15,300) - 15,300 - (15,300) - Licenses - indefinite 7,400 - - 7,400 7,400 - - 7,400 Other intangibles - finite 117,473 - (74,400) 43,073 116,982 - (66,027) 50,955 Total Health & Home 479,086 - (89,700) 389,386 478,595 - (81,327) 397,268 Nutritional Supplements: Goodwill 96,609 (96,609) - - 96,609 - - 96,609 Brand assets - indefinite 20,432 - - 20,432 56,020 - - 56,020 Other intangibles - finite 52,180 - (22,095) 30,085 44,180 - (16,715) 27,465 Total Nutritional Supplements 169,221 (96,609) (22,095) 50,517 196,809 - (16,715) 180,094 Beauty: Goodwill 81,841 (46,490) - 35,351 81,841 (46,490) - 35,351 Trademarks - indefinite 41,854 - - 41,854 45,854 - - 45,854 Trademarks - finite 150 - (96) 54 150 - (92) 58 Licenses - indefinite 10,300 - - 10,300 10,300 - - 10,300 Licenses - finite 13,696 - (12,087) 1,609 13,696 - (11,849) 1,847 Other intangibles - finite 46,402 - (43,885) 2,517 46,402 - (39,929) 6,473 Total Beauty 194,243 (46,490) (56,068) 91,685 198,243 (46,490) (51,870) 99,883 Total goodwill and intangible assets $ 1,299,557 $ (143,099) $ (184,937) $ 971,521 $ 1,330,296 $ (46,490) $ (165,388) $ 1,118,418
Summary of amortization expense attributable to intangible assets	Aggregate Amortization Expense (in thousands) For the three months ended November 30, 2017 $ 6,430 November 30, 2016 7,199 Aggregate Amortization Expense (in thousands) For the nine months ended November 30, 2017 $ 19,578 November 30, 2016 21,625
Schedule of estimated amortization expense of intangible assets	Estimated Amortization Expense (in thousands) Fiscal 2018 $ 26,095 Fiscal 2019 20,604 Fiscal 2020 19,516 Fiscal 2021 16,926 Fiscal 2022 6,450 Fiscal 2023 4,280

Share-Based Compensation Plans

Share-Based Compensation Plans (Tables)	9 Months Ended
	Nov. 30, 2017
Share-Based Compensation Plans
Schedule of share-based compensation expense in S G and A	SHARE-BASED COMPENSATION EXPENSE Three Months Ended Nine Months Ended November 30, November 30, (in thousands, except per share data) 2017 2016 2017 2016 Stock options $ 327 $ 629 $ 1,289 $ 2,036 Directors stock compensation 175 175 575 525 Performance based and other stock awards 4,202 2,151 9,141 8,998 Employee stock purchase plan - - 297 258 Share-based compensation expense 4,704 2,955 11,302 11,817 Less income tax benefits (781) (706) (1,862) (2,920) Share-based compensation expense, net of income tax benefits $ 3,923 $ 2,249 $ 9,440 $ 8,897 Earnings per share impact of share-based compensation expense: Basic $ 0.14 $ 0.08 $ 0.35 $ 0.32 Diluted $ 0.14 $ 0.08 $ 0.35 $ 0.32

Repurchase of Helen of Troy Com

Repurchase of Helen of Troy Common Stock (Tables)	9 Months Ended
	Nov. 30, 2017
Repurchase of Helen of Troy Common Stock
Summary of share repurchase activity	Three Months Ended November 30, Nine Months Ended November 30, (in thousands, except per share data) 2017 2016 2017 2016 Common stock repurchased on the open market or through tender offer: Number of shares 311,100 922,731 311,100 922,731 Aggregate value of shares $ 29,158 $ 75,000 $ 29,158 $ 75,000 Average price per share $ 93.72 $ 81.28 $ 93.72 $ 81.28 Common stock received in connection with share-based compensation: Number of shares 299 961 72,864 6,235 Aggregate value of shares $ 27 $ 83 $ 7,000 $ 590 Average price per share $ 91.94 $ 85.97 $ 96.07 $ 94.60

Commitments and Contingencies (

Commitments and Contingencies (Tables)	9 Months Ended
	Nov. 30, 2017
Commitments and Contingencies
Summary of activity in warranty accrual	Three Months Ended November 30, Nine Months Ended November 30, (in thousands) 2017 2016 2017 2016 Beginning balance $ 22,094 $ 19,459 $ 21,766 $ 20,622 Additions to the accrual 14,473 14,858 40,655 43,052 Reductions of the accrual - payments and credits issued (12,914) (12,457) (38,768) (41,814) Ending balance $ 23,653 $ 21,860 $ 23,653 $ 21,860

Long-Term Debt (Tables)

Long-Term Debt (Tables)	9 Months Ended
	Nov. 30, 2017
Long-Term Debt
Summary of long-term debt	LONG-TERM DEBT Original Date Interest November 30, February 28, (dollars in thousands) Borrowed Rates Matures 2017 2017 Mississippi Business Finance Corporation Loan (the "MBFC Loan") (1) 03/13 Floating 03/23 $ 24,215 $ 29,903 Senior Notes (2) 01/11 3.9 % 01/18 19,976 19,763 Credit Agreement (3) 01/15 Floating 12/21 382,000 435,949 Total long-term debt 426,191 485,615 Less current maturities of long-term debt (20,860) (24,404) Long-term debt, excluding current maturities $ 405,331 $ 461,211 _____________________ (1) The MBFC Loan is unsecured with an original balance of $37.6 million and interest set and payable quarterly at a Base Rate, plus a margin of up to 1.0%, or applicable LIBOR plus a margin of up to 2.0%, as determined by the interest rate elected and the Leverage Ratio. The loan is subject to holder's call on or after March 1, 2018. The loan can be prepaid without penalty. The remaining principal balance of the MBFC Loan is payable as follows: $1.9 million annually on March 1, 2018 through 2022; and $14.8 million on March 1, 2023. Any remaining outstanding principal and interest is due upon maturity on March 1, 2023. (2) $100 million unsecured Senior Notes at a fixed interest rate of 3.9% payable semi-annually. Annual principal payments of $20 million began in January 2014. Prepayment of the notes are subject to a "make whole" premium. (3) Floating interest rates are hedged with and interest rate swap to effectively fix interest rates on $100 million of the outstanding principal balance under the Credit Agreement. Notes 11 and 12 to these consolidated condensed financial statements provide additional information regarding the interest rate swap.

Fair Value (Tables)

Fair Value (Tables)	9 Months Ended
	Nov. 30, 2017
Fair Value
Schedule of fair value hierarchy of financial assets and liabilities presented at fair value and measured on a recurring basis	FAIR VALUES OF FINANCIAL ASSETS AND LIABILITIES Fair Values at November 30, 2017 (in thousands) (Level 2) (1) Assets: Money market accounts $ 496 Interest rate swap and foreign currency contracts 1,023 Total assets $ 1,519 Liabilities: Fixed rate debt (2) $ 20,035 Floating rate debt 406,215 Foreign currency contracts 2,815 Total liabilities $ 429,065 Fair Values at February 28, 2017 (in thousands) (Level 2) (1) Assets: Money market accounts $ 2,711 Foreign currency contracts 2,167 Total assets $ 4,878 Liabilities: Fixed rate debt (2) $ 20,105 Floating rate debt 465,852 Foreign currency contracts 47 Total liabilities $ 486,004 _____________________ (1) Our financial assets and liabilities are classified as Level 2 because their valuation is dependent on observable inputs and other quoted prices for similar assets or liabilities, or model-derived valuations whose significant value drivers are observable. (2) Debt values are reported at estimated fair value in these tables, but are recorded in the accompanying consolidated balance sheets at the undiscounted value of remaining principal payments due.

Financial Instruments and Ris33

Financial Instruments and Risk Management (Tables)	9 Months Ended
	Nov. 30, 2017
Financial Instruments and Risk Management
Schedule of fair values of derivative instruments	FAIR VALUES OF DERIVATIVE INSTRUMENTS November 30, 2017 Prepaid Accrued Expenses Expenses Final and Other and Other Other (in thousands) Settlement Notional Current Other Current Liabilities, Derivatives designated as hedging instruments Hedge Type Date Amount Assets Assets Liabilities Non-current Foreign currency contracts - sell Euro Cash flow 12/2018 € 32,250 $ - $ 2 $ 1,381 $ - Foreign currency contracts - sell Canadian Dollars Cash flow 12/2018 $ 27,750 252 16 - - Foreign currency contracts - sell Pounds Cash flow 01/2019 £ 20,400 - - 765 32 Foreign currency contracts - sell Mexican Pesos Cash flow 05/2018 $ 45,000 - - 159 - Interest rate swap Cash flow 12/2021 $ 100,000 134 619 - - Subtotal 386 637 2,305 32 Derivatives not designated under hedge accounting Foreign currency contracts - cross-currency debt swaps - Euro (1) 4/2020 $ 5,280 - - - 65 Foreign currency contracts - cross-currency debt swaps - Pound (1) 4/2020 $ 6,395 - - - 413 Subtotal - - - 478 Total fair value $ 386 $ 637 $ 2,305 $ 510 February 28, 2017 Prepaid Accrued Expenses Expenses Final and Other and Other Other Settlement Notional Current Other Current Liabilities, Derivatives designated as hedging instruments Hedge Type Date Amount Assets Assets Liabilities Non-current Foreign currency contracts - sell Euro Cash flow 2/2018 € 27,500 $ 727 $ - $ - $ - Foreign currency contracts - sell Canadian Dollars Cash flow 6/2018 $ 26,000 155 32 - - Foreign currency contracts - sell Pounds Cash flow 2/2018 £ 13,500 548 - - - Foreign currency contracts - sell Mexican Pesos Cash flow 2/2018 $ 59,600 - - 47 - Subtotal 1,430 32 47 - Derivatives not designated under hedge accounting Foreign currency contracts - cross-currency debt swap - Euro (1) 1/2018 $ 10,000 705 - - - Total fair value $ 2,135 $ 32 $ 47 $ - _____________________ (1) These are foreign currency contracts for which we have not elected hedge accounting. We refer to them as “cross-currency debt swaps”. They, in effect, adjust the currency denomination of a portion of our outstanding debt to the Euro and British Pound, as applicable, for the notional amounts reported, creating an economic hedge against currency movements.
Schedule of pre-tax effect of derivative instruments	PRE-TAX EFFECT OF DERIVATIVE INSTRUMENTS Three Months Ended November 30, Gain (Loss) Gain (Loss) Reclassified from Recognized in OCI Accumulated Other Comprehensive Gain (Loss) Recognized (effective portion) Income (Loss) into Income As Income (in thousands) 2017 2016 Location 2017 2016 Location 2017 2016 Currency contracts - cash flow hedges $ 2,928 $ 2,049 SG&A $ 1,328 $ 522 $ - $ - Interest rate swaps - cash flow hedges 753 - Interest expense - - Interest expense (48) - Cross-currency debt swaps - principal - - - - SG&A (419) 493 Cross-currency debt swaps - interest - - - - Interest Expense 74 - Total $ 3,681 $ 2,049 $ 1,328 $ 522 $ (393) $ 493 Nine Months Ended November 30, Gain (Loss) Gain (Loss) Reclassified from Recognized in OCI Accumulated Other Comprehensive Gain (Loss) Recognized (effective portion) Income (Loss) into Income As Income (in thousands) 2017 2016 Location 2017 2016 Location 2017 2016 Currency contracts - cash flow hedges $ (1,275) $ 2,319 SG&A $ 2,208 $ 505 $ - $ - Interest rate swaps - cash flow hedges 753 - Interest expense - - Interest expense (48) - Cross-currency debt swaps - principal - - - - SG&A (1,183) 528 Cross-currency debt swaps - interest - - - - Interest Expense 74 35 Total $ (522) $ 2,319 $ 2,208 $ 505 $ (1,157) $ 563

Comprehensive Income (Loss) (Ta

Comprehensive Income (Loss) (Tables)	9 Months Ended
	Nov. 30, 2017
Comprehensive Income (Loss)
Schedule of changes in accumulated other comprehensive income (loss) by component	CHANGES IN ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) BY COMPONENT Unrealized Holding Gains (Losses) on Cash Flow Hedges (in thousands) Interest Rate Swaps (1) Foreign Currency Contracts (2) Total Balance at February 28, 2017 $ - $ 1,173 $ 1,173 Other comprehensive income (loss) before reclassification 753 (1,275) (522) Amounts reclassified out of accumulated other comprehensive income (loss) - (2,208) (2,208) Tax effects (290) 509 219 Other comprehensive income (loss) 463 (2,974) (2,511) Balance at November 30, 2017 $ 463 $ (1,801) $ (1,338) _____________________ (1) Includes net deferred tax benefits of $0.3 million at November 30, 2017. Balances at November 30, 2017 and February 28, 2017 include net deferred tax benefit (expense) of $0.3 and $(0.2) million, respectively .

Segment Information (Tables)

Segment Information (Tables)	9 Months Ended
	Nov. 30, 2017
Segment Information
Schedule of segment information	THREE MONTHS ENDED (in thousands) Nutritional November 30, 2017 Housewares Health & Home Supplements Beauty Total Sales revenue, net $ 128,017 $ 190,975 $ 29,336 $ 104,717 $ 453,045 Asset impairment charges - - 82,227 - 82,227 Restructuring charges - - 118 1,165 1,283 Operating income (loss) 29,982 27,897 (83,521) 10,012 (15,630) Capital and intangible asset expenditures 565 171 1,802 502 3,040 Depreciation and amortization 1,444 4,232 2,374 2,710 10,760 Nutritional November 30, 2016 Housewares Health & Home Supplements Beauty Total Sales revenue, net $ 124,723 $ 179,842 $ 32,163 $ 107,686 $ 444,414 Asset impairment charges - - - - - Restructuring charges - - - - - Operating income (loss) 29,223 20,155 (80) 14,021 63,319 Capital and intangible asset expenditures 1,100 1,492 1,558 624 4,774 Depreciation and amortization 1,429 5,221 2,108 2,467 11,225 NINE MONTHS ENDED (in thousands) Nutritional November 30, 2017 Housewares (1) Health & Home Supplements Beauty Total Sales revenue, net $ 341,165 $ 489,102 $ 92,212 $ 268,633 $ 1,191,112 Asset impairment charges - - 132,297 4,000 136,297 Restructuring charges - - 118 1,165 1,283 Operating income (loss) 71,601 $ 50,187 $ (138,413) $ 17,869 1,244 Capital and intangible asset expenditures 1,166 1,381 14,561 2,746 19,854 Depreciation and amortization 4,290 12,553 7,223 8,296 32,362 Nutritional November 30, 2016 Housewares (1) Health & Home Supplements Beauty Total Sales revenue, net $ 315,302 $ 470,650 $ 101,215 $ 273,355 $ 1,160,522 Asset impairment charges - - 5,000 2,400 7,400 Restructuring charges - - - - - Operating income (loss) 68,956 39,156 (6,581) 22,173 123,704 Capital and intangible asset expenditures 3,938 3,526 3,665 3,860 14,989 Depreciation and amortization 4,200 15,738 6,242 7,143 33,323 _____________________ (1) The nine months ended November 30, 2017 includes a full nine months of operating results for Hydro Flask compared to eight and one-half months for the nine months ended November 30, 2016.

Earnings per Share (Tables)

Earnings per Share (Tables)	9 Months Ended
	Nov. 30, 2017
Earnings per Share
Schedule of weighted average diluted securities	Three Months Ended November 30, Nine Months Ended November 30, (in thousands) 2017 2016 2017 2016 Weighted average shares outstanding, basic 27,113 27,484 27,140 27,700 Incremental shares from share-based compensation arrangements - 318 - 358 Weighted average shares outstanding, diluted 27,113 27,802 27,140 28,058 Dilutive securities, stock options 222 325 236 401 Dilutive securities, unvested or unsettled stock awards 82 163 100 163 Antidilutive securities 354 149 344 142

Basis of Presentation and Rel37

Basis of Presentation and Related Information (Details)	9 Months Ended
	Nov. 30, 2017segment
Basis of Presentation and and Related Information
Number of segments	4

Supplemental Balance Sheet In38

Supplemental Balance Sheet Information (Details) - USD ($) $ in Thousands	9 Months Ended
	Nov. 30, 2017	Feb. 28, 2017
PROPERTY AND EQUIPMENT
Property and equipment, gross	$ 251,474	$ 241,496
Less accumulated depreciation	(118,485)	(106,561)
Property and equipment, net	132,989	134,935
Land
PROPERTY AND EQUIPMENT
Property and equipment, gross	12,800	12,800
Building and improvements
PROPERTY AND EQUIPMENT
Property and equipment, gross	$ 109,108	109,026
Building and improvements | Minimum
PROPERTY AND EQUIPMENT
Estimated useful life	3 years
Building and improvements | Maximum
PROPERTY AND EQUIPMENT
Estimated useful life	40 years
Computer, furniture and other equipment
PROPERTY AND EQUIPMENT
Property and equipment, gross	$ 89,838	81,122
Computer, furniture and other equipment | Minimum
PROPERTY AND EQUIPMENT
Estimated useful life	3 years
Computer, furniture and other equipment | Maximum
PROPERTY AND EQUIPMENT
Estimated useful life	15 years
Tools, dies, molds and other production equipment
PROPERTY AND EQUIPMENT
Property and equipment, gross	$ 33,792	31,157
Tools, dies, molds and other production equipment | Minimum
PROPERTY AND EQUIPMENT
Estimated useful life	1 year
Tools, dies, molds and other production equipment | Maximum
PROPERTY AND EQUIPMENT
Estimated useful life	10 years
Construction in progress
PROPERTY AND EQUIPMENT
Property and equipment, gross	$ 5,936	$ 7,391

Supplemental Balance Sheet In39

Supplemental Balance Sheet Information - Liabilities (Details) - USD ($) $ in Thousands	Nov. 30, 2017	Feb. 28, 2017
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
Accrued compensation, benefits and payroll taxes	$ 31,311	$ 34,917
Accrued sales returns, discounts and allowances	32,050	27,377
Accrued warranty returns	23,653	21,766
Accrued advertising	30,134	23,747
Accrued legal fees and settlements	17,282	16,908
Accrued royalties	10,599	9,553
Accrued property, sales and other taxes	9,509	6,564
Accrued freight and duty	5,480	3,454
Accrued product liability	2,224	2,141
Derivative liabilities, current	2,305	47
Liability for uncertain tax positions	1,024
Other	8,961	6,726
Total accrued expenses and other current liabilities	174,532	153,200
OTHER LIABILITIES, NON CURRENT
Deferred compensation liability	5,988	6,560
Liability for uncertain tax positions	3,467	6,611
Other liabilities	8,420	8,490
Total other liabilities, noncurrent	$ 17,875	$ 21,661

Acquisitions (Details)

Acquisitions (Details) - USD ($) $ in Thousands	Mar. 18, 2016	Nov. 30, 2017	Feb. 28, 2017
Assets
Goodwill		$ 602,320	$ 698,929
Hydro Flask
Acquisitions
Purchase price	$ 209,300
Acquisition-related expenses incurred	700
Assets
Receivables	7,955
Inventory	6,243
Prepaid expenses and other current assets	336
Property and equipment	1,108
Goodwill	116,053
Indefinite-lived intangible assets	59,000
Subtotal - assets	215,195
Liabilities
Accounts payable	2,275
Accrued expenses	3,662
Subtotal - liabilities	5,937
Net assets recorded	$ 209,258
Fair value key assumptions
Discount rate (as a percent)	12.30%
Hydro Flask | Customer relationships
Assets
Finite-lived intangible assets	$ 14,200
Useful life	24 years
Fair value key assumptions
Customer attrition rates (as a percent)	4.00%
Hydro Flask | Technology assets
Assets
Finite-lived intangible assets	$ 10,300
Useful life	10 years
Fair value key assumptions
Royalty rates (as a percent)	2.00%
Hydro Flask | Technology assets | Minimum
Assets
Average life cycle of underlying products	7 years
Hydro Flask | Technology assets | Maximum
Assets
Average life cycle of underlying products	15 years
Hydro Flask | Trade names
Assets
Indefinite-lived intangible assets	$ 59,000
Fair value key assumptions
Royalty rates (as a percent)	6.00%

Goodwill and Intangible Asset41

Goodwill and Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended					9 Months Ended
	Nov. 30, 2017	Aug. 31, 2017	May 31, 2017	Feb. 28, 2017	May 31, 2016	Nov. 30, 2017	Nov. 30, 2016	Mar. 18, 2016
Goodwill and intangible assets
Non-cash intangible asset impairment charges, total						$ 136,297	$ 7,400
Changes in Goodwill
Cumulative Goodwill Impairments	$ (143,099)			$ (46,490)		(143,099)
Goodwill Net Book Value	602,320			698,929		602,320
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, Accumulated Amortization	(184,937)			(165,388)		(184,937)
Goodwill and intangible assets
Gross Carrying Amount	1,299,557			1,330,296		1,299,557
Net Book Value	971,521			1,118,418		971,521
Hydro Flask
Changes in Goodwill
Goodwill Net Book Value								$ 116,053
Housewares
Changes in Goodwill
Goodwill Gross Carrying Amount	282,056			282,056		282,056
Goodwill Net Book Value	282,056			282,056		282,056
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, Accumulated Amortization	(17,074)			(15,476)		(17,074)
Goodwill and intangible assets
Gross Carrying Amount	457,007			456,649		457,007
Net Book Value	439,933			441,173		439,933
Housewares | Other intangible assets
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, Gross Carrying Amount	40,751			40,393		40,751
Intangible assets - finite-lived, Accumulated Amortization	(17,074)			(15,476)		(17,074)
Intangible assets - finite-lived, Net Book Value	23,677			24,917		23,677
Housewares | Trademarks
Changes in intangible assets - indefinite-lived
Intangible assets - indefinite-lived, Gross Carrying Amount	134,200			134,200		134,200
Health and Home
Changes in Goodwill
Goodwill Gross Carrying Amount	284,913			284,913		284,913
Goodwill Net Book Value	284,913			284,913		284,913
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, Accumulated Amortization	(89,700)			(81,327)		(89,700)
Goodwill and intangible assets
Gross Carrying Amount	479,086			478,595		479,086
Net Book Value	389,386			397,268		389,386
Health and Home | Licenses
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, Gross Carrying Amount	15,300			15,300		15,300
Intangible assets - finite-lived, Accumulated Amortization	(15,300)			(15,300)		(15,300)
Health and Home | Other intangible assets
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, Gross Carrying Amount	117,473			116,982		117,473
Intangible assets - finite-lived, Accumulated Amortization	(74,400)			(66,027)		(74,400)
Intangible assets - finite-lived, Net Book Value	43,073			50,955		43,073
Health and Home | Trademarks
Changes in intangible assets - indefinite-lived
Intangible assets - indefinite-lived, Gross Carrying Amount	54,000			54,000		54,000
Health and Home | Licenses
Changes in intangible assets - indefinite-lived
Intangible assets - indefinite-lived, Gross Carrying Amount	7,400			7,400		7,400
Beauty And Nutritional Supplements | Trademarks
Goodwill and intangible assets
Non-cash indefinite-lived intangible assets impairment charges				5,000	$ 7,400
Non-cash indefinite-lived intangible assets impairment charges, net of tax				3,200	$ 5,100
Nutritional Supplements
Goodwill and intangible assets
Non-cash intangible asset impairment charges, total	82,200		$ 32,000
Goodwill impairment charges	70,600		26,000
Non-cash indefinite-lived intangible assets impairment charges	11,600		6,000
Changes in Goodwill
Goodwill Gross Carrying Amount	96,609			96,609		96,609
Cumulative Goodwill Impairments	(96,609)					(96,609)
Goodwill Net Book Value				96,609
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, Accumulated Amortization	(22,095)			(16,715)		(22,095)
Goodwill and intangible assets
Gross Carrying Amount	169,221			196,809		169,221
Net Book Value	50,517			180,094		50,517
Nutritional Supplements | Other intangible assets
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, Gross Carrying Amount	52,180			44,180		52,180
Intangible assets - finite-lived, Accumulated Amortization	(22,095)			(16,715)		(22,095)
Intangible assets - finite-lived, Net Book Value	30,085			27,465		30,085
Nutritional Supplements | Trademarks
Goodwill and intangible assets
Non-cash intangible asset impairment charges, total		$ 18,100
Nutritional Supplements | Brand assets
Changes in intangible assets - indefinite-lived
Intangible assets - indefinite-lived, Gross Carrying Amount	20,432			56,020		20,432
Beauty
Goodwill and intangible assets
Non-cash indefinite-lived intangible assets impairment charges			$ 4,000
Changes in Goodwill
Goodwill Gross Carrying Amount	81,841			81,841		81,841
Cumulative Goodwill Impairments	(46,490)			(46,490)		(46,490)
Goodwill Net Book Value	35,351			35,351		35,351
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, Accumulated Amortization	(56,068)			(51,870)		(56,068)
Goodwill and intangible assets
Gross Carrying Amount	194,243			198,243		194,243
Net Book Value	91,685			99,883		91,685
Beauty | Trademarks
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, Gross Carrying Amount	150			150		150
Intangible assets - finite-lived, Accumulated Amortization	(96)			(92)		(96)
Intangible assets - finite-lived, Net Book Value	54			58		54
Beauty | Licenses
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, Gross Carrying Amount	13,696			13,696		13,696
Intangible assets - finite-lived, Accumulated Amortization	(12,087)			(11,849)		(12,087)
Intangible assets - finite-lived, Net Book Value	1,609			1,847		1,609
Beauty | Other intangible assets
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, Gross Carrying Amount	46,402			46,402		46,402
Intangible assets - finite-lived, Accumulated Amortization	(43,885)			(39,929)		(43,885)
Intangible assets - finite-lived, Net Book Value	2,517			6,473		2,517
Beauty | Trademarks
Changes in intangible assets - indefinite-lived
Intangible assets - indefinite-lived, Gross Carrying Amount	41,854			45,854		41,854
Beauty | Licenses
Changes in intangible assets - indefinite-lived
Intangible assets - indefinite-lived, Gross Carrying Amount	$ 10,300			$ 10,300		$ 10,300

Goodwill and Intangible Asset42

Goodwill and Intangible Assets - Amortization (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 30, 2017	Nov. 30, 2016	Nov. 30, 2017	Nov. 30, 2016
Goodwill and Intangible Assets
Aggregate Amortization Expense	$ 6,430	$ 7,199	$ 19,578	$ 21,625
Estimated Amortization Expense
Fiscal 2,018	26,095		26,095
Fiscal 2,019	20,604		20,604
Fiscal 2,020	19,516		19,516
Fiscal 2,021	16,926		16,926
Fiscal 2,022	6,450		6,450
Fiscal 2,023	$ 4,280		$ 4,280

Share-Based Compensation Plan43

Share-Based Compensation Plans (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended			9 Months Ended
	Nov. 30, 2017	May 31, 2017	Nov. 30, 2016	Nov. 30, 2017	Nov. 30, 2016
SHARE-BASED PAYMENT EXPENSE
Less income tax benefits	$ (781)		$ (706)	$ (1,862)	$ (2,920)
Share-based payment expense, net of income tax benefits	$ 3,923		$ 2,249	$ 9,440	$ 8,897
Earnings per share impact of share-based payment expense:
Basic (in dollars per share)	$ 0.14		$ 0.08	$ 0.35	$ 0.32
Diluted (in dollars per share)	$ 0.14		$ 0.08	$ 0.35	$ 0.32
SG&A
SHARE-BASED PAYMENT EXPENSE
Share-based payment expense	$ 4,704		$ 2,955	$ 11,302	$ 11,817
Employee stock options
Share-based compensation plans
Exercise of stock options (in shares)	7,148			110,552
Restricted stock (RSA) | Directors
Share-based compensation plans
Number of awards granted (in shares)	1,351			4,279
Grant date fair value	$ 100			$ 400
Grant date fair value (in dollars per share)				$ 94.26
Share-based compensation. | Directors | SG&A
SHARE-BASED PAYMENT EXPENSE
Share-based payment expense	175		175	$ 575	525
Performance-based and other stock awards | SG&A
SHARE-BASED PAYMENT EXPENSE
Share-based payment expense	4,202		2,151	9,141	8,998
Employee stock purchase plan | SG&A
SHARE-BASED PAYMENT EXPENSE
Share-based payment expense				297	258
Stock Option Officers Employees and Consultants | SG&A
SHARE-BASED PAYMENT EXPENSE
Share-based payment expense	$ 327		$ 629	$ 1,289	$ 2,036
Restricted Stock Units (RSU)
Share-based compensation plans
Number of awards granted (in shares)				78,352
Grant date fair value (in dollars per share)	$ 93.75			$ 89.22
Restricted Stock Units (RSU) | Employees
Share-based compensation plans
Number of awards granted (in shares)	1,115			35,250
Vested and settled or exercised, total grant date fair value	$ 100			$ 3,500
Vested and settled or exercised, fair value (in dollars per share)				$ 98.13
Performance Stock Units (PSU)
Share-based compensation plans
Number of awards granted (in shares)	3,795			70,329
Grant date fair value (in dollars per share)	$ 92.20			$ 91.54
Vested and settled or exercised, Vested and settled (in shares)		149,884
Vested and settled or exercised, total grant date fair value		$ 14,300
Vested and settled or exercised, average share rice (in dollars per share)		$ 95.55

Repurchase of Helen of Troy C44

Repurchase of Helen of Troy Common Stock (Details) - USD ($) $ / shares in Units, $ in Thousands	May 10, 2017	Nov. 30, 2017	Nov. 30, 2016	Nov. 30, 2017	Nov. 30, 2016
Repurchase of common stock
Amount of shares authorized for purchase	$ 400,000
Period for stock repurchase	3 years
Remaining share repurchase amount - prior program	$ 82,000
Remaining share repurchase amount		$ 364,900		$ 364,900
Common stock repurchased and retired (in shares)		299,000	961,000	72,864,000	6,235,000
Common stock repurchased and retired, total cost or aggregate market value		$ 27	$ 83	$ 7,000	$ 590
Average price per share (in dollars per share)		$ 91.94	$ 85.97	$ 96.07	$ 94.60
Open market or tender offer
Repurchase of common stock
Common stock repurchased and retired (in shares)		311,100	922,731	311,100	922,731
Common stock repurchased and retired, total cost or aggregate market value		$ 29,158	$ 75,000	$ 29,158	$ 75,000
Average price per share (in dollars per share)		$ 93.72	$ 81.28	$ 93.72	$ 81.28

Restructuring Plan (Details)

Restructuring Plan (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended	20 Months Ended
	Nov. 30, 2017	Nov. 30, 2017	May 31, 2019
Restructuring Plan
Restructuring charges	$ 1,283	$ 1,283
Project Refuel
Restructuring Plan
Targeted annualized profit improvement		8,000
Restructuring charges	1,300	1,300
Forecast | Minimum | Project Refuel
Restructuring Plan
Restructuring charges			$ 3,200
Forecast | Maximum | Project Refuel
Restructuring Plan
Restructuring charges			$ 4,800
Beauty
Restructuring Plan
Restructuring charges	1,165	1,165
Beauty | Project Refuel
Restructuring Plan
Cash restructuring payments		500
Restructuring liability	700	700
Beauty | Employee severance and termination benefits | Project Refuel
Restructuring Plan
Restructuring charges	1,200	1,200
Nutritional Supplements
Restructuring Plan
Restructuring charges	118	118
Nutritional Supplements | Project Refuel
Restructuring Plan
Restructuring liability	100	100
Nutritional Supplements | Contract termination costs | Project Refuel
Restructuring Plan
Restructuring charges	$ 100	$ 100

Commitments and Contingencies46

Commitments and Contingencies (Details) $ in Thousands	1 Months Ended		3 Months Ended		9 Months Ended
	Jun. 30, 2016USD ($)	Jan. 31, 2016USD ($)item	Nov. 30, 2017USD ($)	Nov. 30, 2016USD ($)	Nov. 30, 2017USD ($)	Nov. 30, 2016USD ($)
Accrual for warranty returns
Beginning balance			$ 22,094	$ 19,459	$ 21,766	$ 20,622
Additions to the accrual			14,473	14,858	40,655	43,052
Reductions of the accrual - payments and credits issued			(12,914)	(12,457)	(38,768)	(41,814)
Ending balance			$ 23,653	$ 21,860	$ 23,653	$ 21,860
Minimum
Accrual for warranty returns
Product warranty period					2 years
Maximum
Accrual for warranty returns
Product warranty period					5 years
Thermometer Patent Litigation | Litigation
Commitments and contingencies
Number of models | item		2
Charge including legal fees and other related expenses		$ 17,800
Amount of additional pre-judgment compensation	$ 1,500

Long-Term Debt - Schedule (Deta

Long-Term Debt - Schedule (Details)	9 Months Ended
	Nov. 30, 2017USD ($)item	Nov. 30, 2016USD ($)	Sep. 30, 2017	Feb. 28, 2017USD ($)
Long-term debt
Total long-term debt	$ 426,191,000			$ 485,615,000
Less current maturities of long-term debt	(20,860,000)			(24,404,000)
Long-term debt, excluding current maturities	405,331,000			461,211,000
Principal payment made	5,700,000	$ 3,800,000
MBFC Loan
Long-term debt
Face amount	37,600,000
Total long-term debt	24,215,000			29,903,000
Outstanding principal payable on March 1, 2018	1,900,000
Outstanding principal payable on March 1, 2019	1,900,000
Outstanding principal payable on March 1, 2020	1,900,000
Outstanding principal payable on March 1, 2021	1,900,000
Outstanding principal payable on March 1, 2022	1,900,000
Outstanding principal payable on March 1, 2023	$ 14,800,000
MBFC Loan | Base Rate
Long-term debt
Margin (as a percent)	1.00%
MBFC Loan | LIBOR
Long-term debt
Margin (as a percent)	2.00%
Senior Notes
Long-term debt
Face amount	$ 100,000,000
Effective interest rate (as a percent)	3.90%
Principal payment	$ 20,000,000
Total long-term debt	19,976,000			19,763,000
Credit Agreement
Long-term debt
Maximum revolving commitment	$ 1,000,000
Number of alternative methods under which interest on borrowings accrue | item	2
Amount available for borrowings	$ 606,400,000
Maximum amount of additional debt that can be incurred under debt covenants	348,200,000
Total long-term debt	382,000,000			$ 435,949,000
Principal amount hedged	$ 100,000,000
Credit Agreement | Base Rate
Long-term debt
Margin (as a percent)	1.00%
Credit Agreement | LIBOR
Long-term debt
Margin (as a percent)	2.00%
Effective interest rate (as a percent)	1.40%
Credit Agreement | Maximum
Long-term debt
Fixed interest rate (as a percentage)			2.10%
Revolving loan | Credit Agreement
Long-term debt
Amount outstanding	$ 386,000,000
Letter of credit | Credit Agreement
Long-term debt
Amount outstanding	$ 7,600,000

Long-Term Debt - Interest rates

Long-Term Debt - Interest rates (Details) - Credit Agreement	3 Months Ended		9 Months Ended
	Nov. 30, 2017	Nov. 30, 2016	Nov. 30, 2017	Nov. 30, 2016
Minimum
Revolving Line of Credit
Interest rate range during each year (as a percent)	2.50%	2.00%	2.30%	1.90%
Maximum
Revolving Line of Credit
Interest rate range during each year (as a percent)	4.50%	4.30%	4.80%	4.30%

Long-Term Debt - FV, Limit, Int

Long-Term Debt - FV, Limit, Interest Expense (Details) - Senior Notes $ in Millions	Nov. 30, 2017USD ($)
Book value
Long-term debt
Long-term debt	$ 20
Fair Values
Long-term debt
Long-term debt	$ 20

Fair Value (Details)

Fair Value (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended	12 Months Ended
	May 31, 2017	Feb. 28, 2017	May 31, 2016	Nov. 30, 2017	Feb. 28, 2017
Beauty And Nutritional Supplements | Trademarks
Assets measured at fair value on a non-recurring basis
Non-cash impairment charges		$ 5,000	$ 7,400
Non-cash impairment charges after tax		3,200	$ 5,100
Beauty
Assets measured at fair value on a non-recurring basis
Non-cash impairment charges	$ 4,000
Fair Values | Senior Notes
Liabilities:
Long-term debt				$ 20,000
Fair Values | Significant Other Observable Market Inputs (Level 2) | Discounted cash flow analysis | Fixed rate debt
Fair value inputs
Discount rate (as a percent)				0.30%	1.80%
Recurring | Fair Values | Significant Other Observable Market Inputs (Level 2)
Assets:
Total assets		4,878		$ 1,519	$ 4,878
Liabilities:
Total liabilities		486,004		429,065	486,004
Recurring | Fair Values | Significant Other Observable Market Inputs (Level 2) | Foreign currency contracts
Assets:
Cash and cash equivalents				1,023
Derivative assets		2,167			2,167
Liabilities:
Long-term debt		47		2,815	47
Recurring | Fair Values | Significant Other Observable Market Inputs (Level 2) | Floating rate debt
Liabilities:
Long-term debt		465,852		406,215	465,852
Recurring | Fair Values | Significant Other Observable Market Inputs (Level 2) | Senior Notes
Liabilities:
Long-term debt		20,105		20,035	20,105
Recurring | Fair Values | Significant Other Observable Market Inputs (Level 2) | Money market accounts
Assets:
Cash and cash equivalents		$ 2,711		$ 496	$ 2,711

Financial Instruments and Ris51

Financial Instruments and Risk Management (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 30, 2017	Nov. 30, 2016	Nov. 30, 2017	Nov. 30, 2016
Currency Exchange Uncertainties
Sales revenue, net	$ 453,045	$ 444,414	$ 1,191,112	$ 1,160,522
Operating income (loss)	(15,630)	63,319	1,244	123,704
SG&A
Foreign Currency Risk and Currency Exchange Uncertainties
Net foreign exchange gains (losses), including the impact of currency hedges and currency swaps	(2,200)	(100)	(1,500)	(600)
Current income tax expense
Foreign Currency Risk and Currency Exchange Uncertainties
Net foreign exchange gains (losses), including the impact of currency hedges and currency swaps	$ (100)	$ (200)	$ (700)	$ (100)
Net sales revenue | Geographic concentration | International operations - transactions denominated in foreign currencies
Foreign Currency Risk and Currency Exchange Uncertainties
Concentration risk percentage	12.00%	12.00%	12.00%	12.00%

Financial Instruments and Ris52

Financial Instruments and Risk Management - Interest Rate Risk (Details) - USD ($)	1 Months Ended	9 Months Ended
	Sep. 30, 2017	Nov. 30, 2017
Financial instruments and risk management
Floating rate debt		$ 410,300,000
Senior Notes
Financial instruments and risk management
Fixed rate debt		$ 20,000,000
Fixed interest rate (as a percent)		3.90%
Effective interest rate (as a percent)		3.90%
Credit Agreement
Financial instruments and risk management
Amount of outstanding principal effectively converted to fixed rate debt using an interest rate swap	$ 100,000,000
Credit Agreement | Minimum
Financial instruments and risk management
Interest rate (as a percent)	1.50%
Credit Agreement | Maximum
Financial instruments and risk management
Interest rate (as a percent)	2.10%
Base Rate | Credit Agreement
Financial instruments and risk management
Basis spread on variable rate (as percent)		1.00%
LIBOR | Credit Agreement
Financial instruments and risk management
Basis spread on variable rate (as percent)		2.00%
Effective interest rate (as a percent)		1.40%
Interest rate swaps | Credit Agreement
Financial instruments and risk management
Percentage of change of underlying debt floating rate payments offset		100.00%
Swap effective percentage		100.00%

Financial Instruments and Ris53

Financial Instruments and Risk Management - Derivative FV (Details) € in Thousands, £ in Thousands, MXN in Thousands, CAD in Thousands, $ in Thousands	Nov. 30, 2017GBP (£)	Nov. 30, 2017EUR (€)	Nov. 30, 2017CAD	Nov. 30, 2017MXN	Nov. 30, 2017USD ($)	Feb. 28, 2017GBP (£)	Feb. 28, 2017EUR (€)	Feb. 28, 2017CAD	Feb. 28, 2017MXN	Feb. 28, 2017USD ($)
Fair values of derivative instruments in the consolidated balance sheet
Long-term debt					$ 426,191					$ 485,615
Senior Notes
Fair values of derivative instruments in the consolidated balance sheet
Long-term debt					19,976					19,763
Prepaid Expenses and Other Current Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets					386					2,135
Other Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets					637					32
Accrued Expenses and Other Current Liability
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities					2,305					47
Other Liabilities, Non-current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities					510
Designated as hedging instruments | Prepaid Expenses and Other Current Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets					386
Designated as hedging instruments | Other Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets					637
Designated as hedging instruments | Accrued Expenses and Other Current Liability
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities					2,305
Designated as hedging instruments | Other Liabilities, Non-current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities					32
Designated as hedging instruments | Foreign currency contracts | Prepaid Expenses and Other Current Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets										1,430
Designated as hedging instruments | Foreign currency contracts | Other Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets										32
Designated as hedging instruments | Foreign currency contracts | Accrued Expenses and Other Current Liability
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities										47
Designated as hedging instruments | Foreign currency contracts | Sell | Euros
Fair values of derivative instruments in the consolidated balance sheet
Notional Amount | €		€ 32,250					€ 27,500
Designated as hedging instruments | Foreign currency contracts | Sell | Euros | Prepaid Expenses and Other Current Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets										727
Designated as hedging instruments | Foreign currency contracts | Sell | Euros | Other Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets					2
Designated as hedging instruments | Foreign currency contracts | Sell | Euros | Accrued Expenses and Other Current Liability
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities					1,381
Designated as hedging instruments | Foreign currency contracts | Sell | Canadian Dollars
Fair values of derivative instruments in the consolidated balance sheet
Notional Amount | CAD			CAD 27,750					CAD 26,000
Designated as hedging instruments | Foreign currency contracts | Sell | Canadian Dollars | Prepaid Expenses and Other Current Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets					252					155
Designated as hedging instruments | Foreign currency contracts | Sell | Canadian Dollars | Other Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets					16					32
Designated as hedging instruments | Foreign currency contracts | Sell | Pounds
Fair values of derivative instruments in the consolidated balance sheet
Notional Amount | £	£ 20,400					£ 13,500
Designated as hedging instruments | Foreign currency contracts | Sell | Pounds | Prepaid Expenses and Other Current Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets										548
Designated as hedging instruments | Foreign currency contracts | Sell | Pounds | Accrued Expenses and Other Current Liability
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities					765
Designated as hedging instruments | Foreign currency contracts | Sell | Pounds | Other Liabilities, Non-current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities					32
Designated as hedging instruments | Foreign currency contracts | Sell | Mexican Pesos
Fair values of derivative instruments in the consolidated balance sheet
Notional Amount | MXN				MXN 45,000
Designated as hedging instruments | Foreign currency contracts | Sell | Mexican Pesos | Accrued Expenses and Other Current Liability
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities					159
Designated as hedging instruments | Foreign currency contracts | Sell | Australian Dollars
Fair values of derivative instruments in the consolidated balance sheet
Notional Amount | MXN									MXN 59,600
Designated as hedging instruments | Foreign currency contracts | Sell | Australian Dollars | Accrued Expenses and Other Current Liability
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities										47
Designated as hedging instruments | Interest rate swaps
Fair values of derivative instruments in the consolidated balance sheet
Notional Amount					100
Designated as hedging instruments | Interest rate swaps | Prepaid Expenses and Other Current Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets					134
Designated as hedging instruments | Interest rate swaps | Other Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets					619
Not designated under hedge accounting | Other Liabilities, Non-current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities					478
Not designated under hedge accounting | Foreign currency contracts
Fair values of derivative instruments in the consolidated balance sheet
Notional Amount										10,000
Not designated under hedge accounting | Foreign currency contracts | Prepaid Expenses and Other Current Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets										$ 705
Not designated under hedge accounting | Cross currency debt swaps | Euros
Fair values of derivative instruments in the consolidated balance sheet
Notional Amount					5,280
Not designated under hedge accounting | Cross currency debt swaps | Euros | Other Liabilities, Non-current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities					65
Not designated under hedge accounting | Cross currency debt swaps | Pounds
Fair values of derivative instruments in the consolidated balance sheet
Notional Amount					6,395
Not designated under hedge accounting | Cross currency debt swaps | Pounds | Other Liabilities, Non-current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities					$ 413

Fiancial Instruments and Risk M

Fiancial Instruments and Risk Management - Derivative tax effect (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 30, 2017	Nov. 30, 2016	Nov. 30, 2017	Nov. 30, 2016
Pre-tax effect of derivative instruments
Gain/ (Loss) Recognized in OCI (effective portion)	$ 3,681	$ 2,049	$ (522)	$ 2,319
Gain/ (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income	1,328	522	2,208	505
Gain/ (Loss) Recognized as Income	(393)	493	(1,157)	563
Foreign currency contracts | Cash flow hedges
Pre-tax effect of derivative instruments
Gain/ (Loss) Recognized in OCI (effective portion)	2,928	2,049	(1,275)	2,319
Net gains currently reported in accumulated other comprehensive income, to be reclassified into income			$ 2,100
Net gains currently reported in accumulated other comprehensive income, to be reclassified into income, period of time to transfer			12 months
Foreign currency contracts | Cash flow hedges | SG&A
Pre-tax effect of derivative instruments
Gain/ (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income	1,328	522	$ 2,208	505
Interest rate swaps | Cash flow hedges
Pre-tax effect of derivative instruments
Gain/ (Loss) Recognized in OCI (effective portion)	753		753
Gain/ (Loss) Recognized as Income	(48)		(48)
Cross currency debt swaps
Pre-tax effect of derivative instruments
Gain/ (Loss) Recognized as Income	74		74
Cross currency debt swaps | SG&A
Pre-tax effect of derivative instruments
Gain/ (Loss) Recognized as Income	$ (419)	$ 493	$ (1,183)	528
Cross currency debt swaps | Interest expense.
Pre-tax effect of derivative instruments
Gain/ (Loss) Recognized as Income				$ 35

Comprehensive Income (Loss) (De

Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Nov. 30, 2017	Nov. 30, 2016	Nov. 30, 2017	Nov. 30, 2016	Feb. 28, 2017
Components of accumulated other comprehensive loss
Balance			$ 1,173
Tax effects	$ (744)	$ (297)	219	$ (392)
Other comprehensive income (loss)	1,609	1,230	(2,511)	1,422
Balance	(1,338)		(1,338)		$ 1,173
Net deferred tax benefits (expense)	35,404	$ 2,740	54,355	$ 8,713
Interest rate swaps
Components of accumulated other comprehensive loss
Other comprehensive income before reclassification			753
Tax effects			(290)
Other comprehensive income (loss)			463
Balance	463		463
Net deferred tax benefits (expense)			300
Foreign currency contracts
Components of accumulated other comprehensive loss
Balance			1,173
Other comprehensive income before reclassification			(1,275)
Amounts reclassified out of accumulated other comprehensive income			(2,208)
Tax effects			509
Other comprehensive income (loss)			(2,974)
Balance	(1,801)		(1,801)		1,173
Net deferred tax benefits (expense)					(200)
Accumulated other comprehensive income (loss)
Components of accumulated other comprehensive loss
Balance			1,173
Balance	$ (1,338)		(1,338)		$ 1,173
Unrealized Holding Gains (Losses) On Cash Flow Hedges
Components of accumulated other comprehensive loss
Other comprehensive income before reclassification			(522)
Amounts reclassified out of accumulated other comprehensive income			(2,208)
Tax effects			219
Other comprehensive income (loss)			(2,511)
Unrealized Holding Gains (Losses) On Cash Flow Hedges | Foreign currency contracts
Components of accumulated other comprehensive loss
Net deferred tax benefits (expense)			$ 300

Segment Information (Details)

Segment Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 30, 2017	Nov. 30, 2016	Nov. 30, 2017	Nov. 30, 2016	Feb. 28, 2017
Segment information
Sales revenue, net	$ 453,045	$ 444,414	$ 1,191,112	$ 1,160,522
Asset impairment charges	82,227		136,297	7,400
Restructuring charges	1,283		1,283
Operating income (loss)	(15,630)	63,319	1,244	123,704
Identifiable assets	1,774,895		1,774,895		$ 1,813,096
Capital and intangible asset expenditures	3,040	4,774	19,854	14,989
Depreciation and amortization	10,760	11,225	32,362	33,323
Housewares
Segment information
Sales revenue, net	128,017	124,723	341,165	315,302
Operating income (loss)	29,982	29,223	71,601	68,956
Capital and intangible asset expenditures	565	1,100	1,166	3,938
Depreciation and amortization	1,444	1,429	4,290	4,200
Health and Home
Segment information
Sales revenue, net	190,975	179,842	489,102	470,650
Operating income (loss)	27,897	20,155	50,187	39,156
Capital and intangible asset expenditures	171	1,492	1,381	3,526
Depreciation and amortization	4,232	5,221	12,553	15,738
Nutritional Supplements
Segment information
Sales revenue, net	29,336	32,163	92,212	101,215
Asset impairment charges	82,227		132,297	5,000
Restructuring charges	118		118
Operating income (loss)	(83,521)	(80)	(138,413)	(6,581)
Capital and intangible asset expenditures	1,802	1,558	14,561	3,665
Depreciation and amortization	2,374	2,108	7,223	6,242
Beauty
Segment information
Sales revenue, net	104,717	107,686	268,633	273,355
Asset impairment charges			4,000	2,400
Restructuring charges	1,165		1,165
Operating income (loss)	10,012	14,021	17,869	22,173
Capital and intangible asset expenditures	502	624	2,746	3,860
Depreciation and amortization	$ 2,710	$ 2,467	$ 8,296	$ 7,143
Hydro Flask | Housewares
Segment information
Period of operating results of acquisition included				8 months 15 days

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended			9 Months Ended
	Feb. 28, 2018	Nov. 30, 2017	Nov. 30, 2016	Nov. 30, 2017	Nov. 30, 2016
Income tax expense (benefit) as a percent of income before income taxes		(58.40%)	3.70%	(59.50%)	7.00%
Tax benefit recorded related to the recognition of excess tax benefits from share-based compensation				$ 2.6	$ 1.6
Tax benefit recorded related to the resolution of an uncertain tax position				$ 2.8	1.4
Tax benefit recorded related to the finalization of certain tax returns					$ 1.2
Forecast
Tax benefits expected to be realized on asset impairment charges	$ 52.8

Earnings per Share (Details)

Earnings per Share (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Nov. 30, 2017	Nov. 30, 2016	Nov. 30, 2017	Nov. 30, 2016
Weighted average diluted securities
Weighted average shares outstanding, basic	27,113	27,484	27,140	27,700
Incremental shares from share-based payment arrangements		318		358
Weighted average shares outstanding, diluted	27,113	27,802	27,140	28,058
Employee and Directors stock options
Weighted average diluted securities
Dilutive securities (in shares)	222	325	236	401
Restricted stock (RSA)
Weighted average diluted securities
Dilutive securities (in shares)	82	163	100	163

Earnings per Share - Antidiluti

Earnings per Share - Antidilution (Details) - shares	3 Months Ended		9 Months Ended
	Nov. 30, 2017	Nov. 30, 2016	Nov. 30, 2017	Nov. 30, 2016
Employee and Directors stock options
Antidilutive securities
Antidilutive securities (in shares)	354,000	149,000	344,000	142,000
Share-based compensation.
Antidilutive securities
Antidilutive securities (in shares)	154,255		164,017

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent event - Healthy Directions LLC $ in Millions	Dec. 20, 2017USD ($)
Subsequent Event
Purchase price from sale	$ 46
Supplemental payment target value	$ 25